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ABSTRACT 
 
Introduction: The global burden of non-communicable diseases (NCDs) has long been 
neglected, with the omission of NCDs from the Millennium Development Goals (MDGs) 
bearing testament to this. The growing prevalence of chronic cardio-metabolic diseases in 
South Africa places huge demands on the health system. This study sought to determine 
the community prevalence of these cardio-metabolic diseases and associated risk factors 
in Chiawelo, Soweto – a township undergoing rapid urbanization in the Johannesburg 
Health District.  
Methods: The study comprised 337 participants: 124 male and 213 female. This was a 
community based cross sectional survey using questionnaires, anthropometric and 
biochemical measurement of HbA1c. Cluster sampling techniques identified eligible adult 
participants. Regression models were performed to identify factors associated with 
disease. Ethical approval to conduct the study was obtained from the University of the 
Witwatersrand and written informed consent was obtained from the participants.  
Results: The study population was black with middle to higher socio-economic status 
and education levels below Grade 12 mostly. The prevalence of diabetes mellitus (DM) 
in this study population was 14%, with many undiagnosed and those with disease poorly 
controlled. More than half the study population had hypertension (HPT) (58%) and most 
were poorly controlled. This was a markedly obese population (39%) with 54% of 
women having a body mass index (BMI) categorised as obese (BMI ≥ 30 kg/m2).  
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Conclusions:  The burden of chronic cardio-metabolic diseases in the Johannesburg 
Health District has been grossly underestimated. The prevalence of HPT and DM was 
high and both diseases were poorly controlled with obesity reaching epidemic 
proportions. Countering the burden of disease involves targeting females as a high risk 
priority group, engaging the community in health promotion and developing a NCD 
surveillance system. Clinically, it is the findings of this study to support the screening of 
cardio-metabolic diseases from as early as 30 years of age in males and 40 years of age in 
females. 
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GLOSSARY OF TERMS 
 
Diabetes mellitus:  For the purposes of this study, diabetes mellitus was classified using 
the American Diabetes Association classification of glycated haemoglobin (HbA1c) (1): 
 Normal: < 5.7% 
 Impaired glucose tolerance (IGT): 5.7 – 6.4% 
 Diabetes: ≥ 6.5% 
Those with IGT have been referred to as having pre-diabetes, indicating the relatively 
high risk for the future development of diabetes.  
 
Dyslipidaemia: Refers to a clinically significant alteration in the circulating lipids and 
lipoproteins predisposing to coronary artery disease (2). The 2000 South African clinical 
guideline for the classification of hypercholesterolaemia (mmol/ℓ) is as follows (3):   
 
 Desirable 
lipid profile 
Hypercholesterolaemia 
 Moderate Severe 
Total cholesterol ≤ 5.0 5.0 – 7.5 > 7.5 
LDL-cholesterol ≤ 3.0 3.0 – 5.0 > 5.0 
HDL-cholesterol ≥ 1.2 variable variable 
Triglycerides ≤ 1.5 < 1.5 < 1.5 
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Epidemiological transition: The term „epidemiologic transition‟ describes the change in 
disease patterns associated with economic development (4). There has been a drastic shift 
in mortality from infectious disease and malnutrition before the 1900s to CVD and cancer 
currently in most high-middle income countries (5). 
 
Hypertension(6): The Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure was used to define 
hypertension:  
 
BP classification SBP (mmHg) DBP (mmHg) 
Normal  <120 and < 80 
Prehypertension 120 - 139 or 80 - 89 
Stage 1 hypertension 140 - 159 or 90 - 99 
Stage 2 hypertension ≥ 160 or ≥ 100 
 
 
Patients with prehypertension are at increased risk for progression to hypertension; those 
in the 130–139/80–89 mmHg BP range are at twice the risk to develop hypertension as 
those with lower values. The classification “prehypertension” signals the need for 
increased education of health care professionals and the public to reduce BP levels and 
prevent the development of hypertension in the general population.  
 
Insulin resistance (7): Resistance to insulin-mediated glucose uptake is characteristic of 
individuals with impaired glucose intolerance or non-insulin-dependent diabetes. It also 
occurs commonly in patients with high blood pressure. 
xviii 
 
Metabolic syndrome: Represents a constellation of inter-related risk factors of metabolic 
origin  that include diabetes mellitus, hypertension, obesity and dyslipidaemia (8). The 
International Diabetes Federation defines the metabolic syndrome as (9):  
 
Central obesity (defined as waist circumference of ≥ 94cm for males and ≥ 80cm for 
females) plus any two of the following four factors:  
 
Raised triglycerides  ≥ 1.7 mmol/ℓ 
  Or specific treatment for this lipid abnormality 
Reduced HDL cholesterol   1.03 mmol/ℓ (males) or 1.29 mmol/ℓ (females) 
  Or specific treatment for this lipid abnormality 
Raised blood pressure  SBP ≥ 130 mmHg or diastolic BP ≥ 85 mmHg 
  Or treatment of previously diagnosed hypertension 
Raised fasting plasma glucose  ≥ 5.6mmol/ℓ 
  Or previously diagnosed type 2 diabetes 
 
 
 
 
 
 
 
 
xix 
 
Obesity and overweight: BMI is defined as weight in kilograms divided by the square of 
height in metres (kg/m
2
) (10). The World Health Organisation defines the following 
weight categories (11):  
 
Classification BMI (kg/m
2
) 
Underweight < 18.50 
Normal range 18.50 - 24.99 
Overweight ≥ 25.00 
Obese ≥ 30.00 
- Obese class I 30.00 - 34-99 
- Obese class II 35.00 - 39.99 
- Obese class III ≥ 40.00 
Source: Adapted from WHO 1995, WHO 2000 and WHO 2004 
 
Residual values: The difference between the observed and predicted values in a 
regression model.   
 
Risk factor: Refers to an attribute, characteristic, or exposure of an individual, which 
increases the likelihood of developing a non-communicable disease (12).  
 
Studentized residual values: This is the residual value divided by the standard 
error/standard deviation of the value.  
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CHAPTER 1 
INTRODUCTION 
 
This chapter outlines the background and justification for the study. The aim and 
objectives of the study are described and the subsequent chapters are detailed. 
 
1.1 BACKGROUND 
 
1.1.1 The global impact of chronic diseases 
 
The United Nations (UN) member states will gather in New York in September 2011 for 
the first UN High-level Summit (UN Resolution 64/265) on non-communicable diseases 
(NCDs) (13). High on the agenda for discussion is the prevention, early detection, 
diagnosis and management and importantly, the investment in effective and measurable 
national control programmes for these diseases (13).  
 
The Millennium Development Goals (MDGs) were launched in 2000. Three of these goals 
focus specifically on  health issues (14):   
 MDG 4:  Reduce child mortality 
 MDG 5:  Improve maternal health 
 MDG 6: Combat Human Immuno-deficiency Virus (HIV) and Acquired Immuno-
Deficiency Syndrome (AIDS), malaria and other diseases  
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Non-communicable diseases, which are a substantial cause of death and disability globally, are a 
very apparent omission from this list of ambitious targets intended to improve the lives of 
people, particularly the poorest, all over the world.  Health and development are inextricably 
linked; one cannot be achieved without the other. The exclusion of NCDs from the MDGs has 
been a major barrier to securing funding for NCDs as many donors exclusively fund the health 
priorities contained within the MDGs (15).  
.  
Attempting to prioritise NCDs has been on the global health agenda for a more than a 
decade. From as early as May 2000, the resolution on Prevention and Control on non-
communicable diseases (WHA53.17) was adopted at the 53rd World Health Assembly 
(WHA) in recognition of the growing epidemic of these chronic diseases (16;17). The 
fundamental outcomes of this assembly called for establishing programmes for the 
prevention and control of NCDs, assessing and monitoring morbidity attributable to 
NCDs, promoting the effectiveness of secondary and tertiary prevention and supporting 
the development of guidelines for cost-effective screening, diagnosis and treatment for 
NCDs (16).  
 
The 2011 Summit represents the biggest and best opportunity to put NCDs on the global 
agenda. The Summit has the potential to secure commitment from heads of government for a 
coordinated global response to NCDs through substantial increases in financial resources 
allocated to NCDs (15;18). This broad political and financial commitment will save millions 
from premature death and debilitating health complications.  
 
 
3 
 
Chronic cardio-metabolic diseases, particularly cardiovascular disease (CVD) and 
diabetes mellitus (DM), represent 43% of the global burden of disease and account for 
50% of all mortality worldwide (19); with an increase in mortality to 73% anticipated by 
2020 (20). Given this enormous burden of disease, it is not surprising that NCDs are 
being considered in global development targets, most notably the successor goals to the 
current MDGs that are set to expire in 2015 (13).  
 
The metabolic syndrome (MS) is an important concept in chronic disease management 
and control. Defined as ‘multiple, interrelated risk factors of metabolic origin that appear 
to directly promote the development of atherosclerotic cardiovascular disease’, the MS 
represents a constellation of diseases that include DM, hypertension (HPT), obesity and 
dyslipidaemia (8). There has been a striking increase in the global prevalence of the MS 
with obesity and DM being the major contributing culprits (21). The underlying risk 
factors (defined in: Glossary of terms) to each of these diseases are well documented and 
their prevention and control, through comprehensive population-based programmes, have 
time and again proven to be the most cost-effective interventions to counter the emerging 
epidemic (12). For the purposes of this study, the MS is defined as described in Chapter 
3: 3.6.1.2 Clinical variables (Metabolic syndrome).  
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1.1.2 Chronic diseases in developing countries 
 
The overall age-specific rates of NCDs are higher in sub-Saharan Africa than in 
populations in Established Market Economies (22). Developing countries have competing 
health demands that restrict the capacity of their resource-limited health services from 
curbing the dramatic increases in the burden of NCDs (12). This translates to a growing 
prevalence of diseases as HPT and DM, particularly in urban areas, placing additional 
huge demands on the health care system (22).  
 
Much of this increase in NCDs in developing countries result from the „epidemiological 
transition‟ (defined in: Glossary of terms), adoption of poor diet and sedentary lifestyles 
(20) and high levels of illiteracy (23). Studies have shown the need for health care 
providers to incorporate patient education and evidence-based measures to reduce the risk 
of CVD and DM through global risk assessment and screening complimented by lifestyle 
modification  (24).  
 
1.1.3 Chronic diseases in South Africa 
 
South Africa is in the midst of a health transition that is characterised by the 
simultaneous, quadruple burden of poverty related infectious diseases (including HIV 
infection) and a rise in NCDs, in a population facing a profound level of perinatal and 
maternal disorders, injury, and violence (25). Health system strengthening, globally and 
in South Africa, focuses much attention on maternal and child health and infectious 
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diseases with a lesser emphasis placed on chronic diseases (26;27). The fact remains that 
South Africa constitutes one of the 23 countries globally that are responsible for 80% of 
the burden of chronic diseases in all middle-income and low-income countries combined 
(26). Aside from urbanisation and its perils, there is a growing prevalence of chronic 
disease risk factors in the rural areas of South Africa as well, placing this population at 
increased risk of developing a CVD event in the following ten years (28).  
 
HIV infection, and not cardiovascular disease, is the leading cause of mortality in South 
Africa with the infection rate being the highest in the world (5.4 million people infected 
in 2006) (29;30). The complex interaction between HIV and CVD (the second largest 
contributor to mortality in South Africa) should not be under-emphasized as HIV 
infection and highly active anti-retroviral therapy (HAART) are clearly implicated in the 
pathogenesis of CVD adding to the overwhelming burden of NCDs in South Africa (29).  
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1.2 JUSTIFICATION FOR THE STUDY 
 
Leading a multi-sectoral response to NCDs requires mapping the emerging epidemiology 
of NCDs, reducing the levels of exposure of individuals to the modifiable risk factors and 
strengthening the health system to combat NCDs through the development of evidence-
based standards and norms (31). It is well documented that low-income and middle-
income countries lack the health system capacity and surveillance infrastructure to 
adequately reduce the disease burden and both these structures need to be urgently 
strengthened (32). Most of the available NCD data have been generated outside of Africa 
and it is unclear how transferable this causation and prevention data is to Africans given 
their differing social, economic and cultural structures (22). Reliable data on the burden 
and causes of NCDs in sub-Saharan Africa is known to be lacking (22). Thus, the logical 
first step to any NCD surveillance programme would be to conduct a baseline survey of 
the target population. The surveillance data generated would allow for more accurate 
prediction of incidence and prevalence rates within the community which is essential for 
interventions aimed at reducing morbidity and mortality.  
 
Efforts to scale-up interventions in low-income and middle-income countries generally 
tend to concentrate on a single disease resulting in a service that is fragmented and 
vertical (33). The South African health care system adopts a similar approach. These 
efforts represent continued missed opportunities to providing comprehensive chronic 
disease care. Screening for a cluster of related diseases thus makes more sense, as it 
would allow for earlier diagnosis and management of NCDs.  
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This study will provide broad insights into the prevalence of CVD risk factors in the 
South African black population as the urban community of Soweto represents the largest 
township in sub-Saharan Africa with the highest concentration of black Africans on the 
continent (34). The study will also provide the initial surveillance data for NCDs in this 
community – an initiative that would contribute to the planning and organisation of 
health services tailored to the needs of the community.  
 
1.3 AIM AND OBJECTIVES 
 
1.3.1  Aim  
 
 
To determine the prevalence of cardio-metabolic diseases and the associated risk factors 
in the community of Chiawelo, Johannesburg Health District, Gauteng Province with a 
view to reducing the burden of disease in terms of long term management and 
development of complications.  
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1.3.2  Objectives  
 
1. To describe the study population in terms of socio-demographic factors 
2. To explore the prevalence and risk factors associated with the 
development of the following cardio-metabolic diseases:  
a. Diabetes mellitus 
b. Hypertension 
c. Obesity 
3. To examine the associations among these major risk factors  
4. To determine the community prevalence of the MS and the major risk 
factors that predispose individuals in this community to the development 
of the MS (as defined in Chapter 3: 3.6.1.2 Clinical variables (Metabolic 
syndrome)  
 
1.4 SUBSEQUENT CHAPTERS OF THIS REPORT 
 
Thus far, the background to the research has been explained and the objectives have been 
defined. The subsequent chapters will focus on: 
 
Chapter 2: Literature review 
The purpose of the literature review is to discuss key concepts and examine potential 
solutions to the research problem. 
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Chapter 3: Study methods and materials 
This chapter describes the research methodology used to conduct this study. 
 
Chapter 4: Results 
This chapter presents the data analysis according to the aim and objectives. 
 
Chapter 5: Discussion 
The literature review is integrated with the study findings from the preceding chapter in 
view of the aim and objectives of the study. 
 
Chapter 6: Conclusions and recommendations 
In this chapter, conclusions are drawn from the report, and suggestions are formulated 
considering the current literature and the findings of the study. 
 
1.5 SUMMARY OF THE CHAPTER 
 
This introductory chapter described the background to the study, the justification for the 
research and the objectives of the study. A summary of the subsequent chapters were then 
briefly described. 
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CHAPTER 2 
LITERATURE REVIEW 
 
This chapter examines the current literature on cardio-metabolic diseases in the context of 
the individual, the prevalence of these diseases and the South African health system. The 
epidemiological transition in South Africa is explored and finally the components of a 
NCD surveillance strategy are discussed.  
 
2.1 INTRODUCTION  
 
„Governments have a responsibility to support their citizens in their pursuit of a healthy, 
long life. It is not enough to say, we have told them not to smoke, we have told them to eat 
fruit and vegetables, we have told them to take regular exercise. We must create 
communities, schools and workplaces and markets that make these healthy choices 
possible. We must tackle this problem step by step and we must start now.‟ ~ Nigerian 
President Olusegun Obasanjo (35).   
 
Chronic cardio-metabolic diseases are a growing cause of death and disability in South 
Africa. As the country moves through an „epidemiological transition‟, the determinants 
and risk factors for disease development changes (36). 
 
It is vital to understand the 
inherent risk factors within the community to understand the context in which disease 
develops.  
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The relationship between the community and the health services in managing these 
conditions also needs to be explored. This understanding serves as a foundation to plan 
appropriate interventions and allocate resources.  
 
2.2 THE IMPACT OF CARDIO-METABOLIC DISEASES 
 
2.2.1 Global impact 
 
 
Cardio-metabolic diseases are a matter of global concern. It is predicted that the 
incidence of DM will double by 2025 and this will be paralleled by an inevitable rise in 
CVD (9). The complications of DM and CVD and the resultant blindness, amputation 
and renal failure account for much of the social and financial burden (9).  
 
The nine million deaths that NCDs are responsible for in people younger than 60 years of 
age annually bears testament to the magnitude of the problem and the earlier onset of 
disease (13). There are increasing numbers of children afflicted with these diseases, 
especially obesity and DM (37) and it must be appreciated that interventions targeting 
children have many health gains, albeit in the longer term (38).  The impact that this will 
have on global healthcare systems is phenomenal. 
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2.2.2 Developing countries 
 
It is globally predicted that mortality attributable to NCDs will increase by 77% from 
1990 – 2020 (17).  Four African countries, including South Africa, feature in the list of 
the 23 countries that account for 80% of the total chronic disease mortality burden in 
developing countries (39) where the majority of these deaths will occur (17). Regional 
World Health Organization (WHO) data from 2005 indicated that chronic metabolic 
diseases accounted for 23% of all deaths in the African region (40). If no effective 
measures are put in place, an estimated US $ 84 billion of national income will be lost 
from heart disease, CVA, and DM alone in these 23 countries between 2006 – 2015 (39).  
 
In the poorest of sub-Saharan countries, chronic metabolic diseases are becoming more 
prevalent despite communicable diseases continuing to predominate. Evidence of DM 
and HPT are on the increase in some urban African settings, but also in rural African 
settings (28). As urbanization increases, so too does the burden of chronic diseases. By 
2015, it is estimated that the mortality in Africa from communicable diseases will be 
exceeded by chronic metabolic diseases (4).  It is therefore imperative that greater 
emphasis is placed on the prevention and control of these diseases.  
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2.2.3 South Africa 
 
The South African health services are grappling with the quadruple burden of disease: 
pre-transitional diseases of poverty and underdevelopment, the chronic diseases of 
lifestyle due to urbanization, injuries (intentional and unintentional) and HIV/AIDS (41). 
South Africa has limited resources but multiple demands are being placed on the health 
services. Chronic metabolic diseases do not pose a significant priority when competing 
with acute conditions such as trauma and communicable diseases (36). As a result, 
provisions made for these diseases are unlikely to be adequate and programmes aimed at 
combating the emergence of associated risk factors probably receive the least attention in 
South Africa‟s health related activities (36). 
 
2.3 CARDIO-METABOLIC DISEASES AND ASSOCIATED RISK FACTORS 
 
2.3.1 Cardiovascular disease 
 
Cardiovascular mortality increases substantially with higher, more poorly controlled 
levels of blood glucose, accounting for 1 490 000 deaths from ischaemic heart disease 
(IHD), 709 000 deaths from CVA and 959 000 deaths directly associated with DM (42). 
A global CVD epidemic is evolving with twice as many deaths in developing countries as 
in developed countries (43). High blood pressure (BP), high cholesterol levels, tobacco 
and alcohol use and poor diet are emerging as major risk factors for CVD (5).  
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In addition to the morbidity and mortality, CVD poses a great financial burden to 
developing countries to both the health care system and to the national economy (5). 
Figures from as early as 1991 showed that South Africa devoted two to three percent of 
the country‟s gross national income or approximately 25% of the health expenditure on 
the treatment of CVD  (44). The fact that a high proportion of CVD falls on adults of 
working age has a further impact on the economy. Conservative estimates indicate that in 
five countries (including South Africa), at least 21 million years of future productive life 
are lost due to CVD annually (5). 
 
Numerous previous cross sectional studies conducted in South Africa had decisively 
shown that people living a larger proportion of their lives in an urban setting had 
significantly higher rates of DM and HPT than those who had spent a smaller proportion 
of their lives in the city (45;46). This picture is quickly changing. The effects of 
urbanization on the development of these chronic diseases are starting to be felt with the 
constant migration of people into the urban areas. The aetiology of the higher levels of 
CVD and mortality in the black population than the white population seems to multi-
factorial with obesity, urbanisation and adoption of a Westernised lifestyle having a huge 
contributory role (47).  
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2.3.2 Diabetes mellitus 
 
 
Diabetes mellitus is a global epidemic which drastically impacts on the quality of life of 
those affected. By 2008, the global prevalence of DM was estimated at 171 million, with 
an expected increase to 366 million by 2030 (48). The rapid rates of urbanisation and 
poor lifestyle choices made are largely responsible for this (49). Historically, DM had 
been a disease restricted to affluent urban areas but the effects of Westernisation have 
resulted in the disease being more and more prevalent in the rural black populations (50). 
Sub-Saharan Africa has an escalating burden of DM mostly resulting from lifestyle 
factors encompassing low levels of physical activity, poor dietary choices laden with fat 
and energy and high levels of obesity (49;51;52). 
 
The burden of DM in South Africa is also unacceptably high with rates higher than the 
African average (53). In 2000, mortality from DM was estimated at 20 000 which 
accounted for 4.3% of all deaths in South Africa – the 7th commonest cause of death in 
the country (53). Diabetes mellitus prevalence rates of between 3 – 10% have been noted 
urban and peri-urban areas in South Africa, a stark contrast to the less than 1% noted 
between the 1960s – 1980s (49). The Framingham Heart Study also demonstrated a 
doubling of DM incidence between the 1970s-1990s in 3104 participants aged between 
the 40 – 55 years who were initially free of DM (52). To complicate matters further, the 
INTERHEART study found DM was a prominent risk factor for MI in black South 
Africans (42).   
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The consequences of DM are sobering. Those with DM are at an increased risk of CVD, 
blindness and renal failure (54). This highlights the importance of the MS as it is a 
recognised  precursor to DM and CVD (55). There is limited research on the incidence of 
DM in South Africa, yet despite this, there is clear evidence suggesting that under-
diagnosis of DM is occurring (56).  
 
2.3.3 Hypertension 
 
Hypertension is a commonly occurring chronic disease that is universally under-
diagnosed and poorly treated resulting in extensive target organ damage and death (36). 
Hypertension is responsible for a growing burden of disease both of established 
importance in middle-income countries and of emerging importance in low-income 
countries (57). In the year 2000, estimates suggest that HPT accounted for 47 000 deaths 
in South Africa which represents 9% of all mortality and 2.4% of total disability adjusted 
life years (DALY) (57).  
 
Hypertension is the most common CVD risk factor among the black population with a 
prevalence of 59% (58). The INTERHEART study reinforced the predilection that 
cardio-vascular complications associated with HPT has for the black population (42). 
Urbanisation predisposes the black population to developing HPT, a trend that will 
continue to grow as urbanisation continues to flourish (57). People living in Gauteng 
report higher prevalence of HPT than the national figures. This is likely due to urban 
environments, such as Gauteng, tending to have higher salt consumption, increased 
alcohol consumption and tobacco use and unhealthier diets (56).  
17 
 
In a study conducted in Gauteng of 40 black patients with established CAD, it was found 
that 95% had previously diagnosed HPT with 50% having elevated glucose 
concentrations (59).  Research has shown that the rural/urban divide in HPT prevalence is 
not as apparent anymore, with levels similar to those in urban areas being seen in rural 
areas (56).  
 
2.3.4 Obesity 
 
The WHO estimates that globally about one billion adults are overweight and about 300 
million are clinically obese (5). This is paralleled by increases in childhood obesity that 
result in increased levels of DM and HPT (5). Accumulation of abdominal fat, 
particularly in the visceral compartment, is associated with an increased risk of insulin 
resistance, DM, HPT, dyslipidaemias and atherosclerosis (60). This visceral adiposity is 
the cornerstone of the MS.  
 
Despite South Africa‟s pressing concerns of under-nutrition, poverty and infectious 
diseases such as HIV and tuberculosis, more than 29% of males and 56% of females were 
classified as obese or overweight (61). The 1998 South African Demographic and Health 
Survey (SADHS) analysed data from 7726 South African women aged 15 – 95 years old 
and found the highest prevalence of overweight and obesity in the female black 
population (59%) (61). The report also showed associated higher BMI with women from 
urban areas and increasing age with central obesity particularly prevalent in urban black 
females (42%) (61).   
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Health promotion and prevention strategies are becoming increasingly more important 
when considering the growing levels of childhood obesity and chronic diseases. The 1999 
South Africa National Food Health Consumption Survey showed that the national 
average of being overweight in children aged 1 - 9 years was 6% while only 5% were 
classified as „wasted‟ and almost 25% as „stunted‟ (37). Children who are obese at six 
years of age have a probability exceeding 50% of obesity in adulthood, particularly if the 
parents are overweight (62).  
 
There are many social considerations to obesity in South Africa. Many black women 
perceive being overweight as desirable (63), despite Western ideas to the contrary. This 
belief is promulgated by the idea that being thin is associated with having HIV/AIDS 
infection, and thus being thin stigmatises the individual as such (63). Larger body sizes in 
the black community is also associated with affluence and happiness (63). Obesity or 
overweight in females is thought to reflect on a husband‟s ability to care for his wife and 
family (64). These factors culminate in obesity being a growing epidemic in South 
Africa. Primordial prevention should be addressed, especially from an early age, by 
promoting physical activity and encouraging healthy diets.  
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2.3.5 Dyslipidaemia 
 
Dyslipidaemia includes hypertriglyceridaemia, reduced HDL cholesterol and usually 
hypercholestrolaemia and forms part of the insulin resistance syndrome (65;66).  
Dyslipidaemia remains a major risk factor for CVD in the South African population and 
is increasing with the progressive urbanisation of the black population (56). In 2000, 
South African data showed that 59% of IHD and 29% of ischaemic stroke was 
attributable to raised cholesterol levels (67).   
 
Previous South African studies have documented that 28% of black African people aged 
30 years and over had cholesterol levels in excess of the clinical cut-off point of 5mmol/ℓ 
(67). Higher cholesterol levels have been found in younger black South Africans 
implicating the earlier adoption of a Westernised lifestyle (67). This finding suggests that 
screening for high cholesterol in the black population begin as early as 30 years of age 
(67). Individuals resident in Gauteng report higher levels of hyperlipidaemia prevalence 
than national rates, again largely attributable to the adoption of a Westernised lifestyle 
(56). Females seem to be more afflicted than the male population; but this probably 
reflects the better health-seeking behaviour in females (67).  
 
The HIV epidemic has to be considered when evaluating hyperlipidaemia as HAART is 
directly responsible for metabolic changes resulting in truncal obesity and changes in the 
composition of lipids (56). 
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Again, dyslipidaemia is inextricably linked to other chronic diseases with at least 30 – 
50% of patients with DM having abnormal lipid patterns and similar rates reported 
among the hypertensives (65;67). Current data suggests that dyslipidaemia in South 
Africa is not a commonly recognized entity. As such, it is rarely diagnosed and poorly 
treated (67). If the South African health system is to have some semblance of control over 
the IHD and CVA rates, dyslipidaemia recognition and management needs to be 
drastically improved.  
 
2.3.6 Physical inactivity and poor dietary choices 
 
Evidence points to the growing prevalence of CVD and DM being largely attributed to 
lifestyle-dependant risk factors such as poor levels of physical activity, transition in diets 
that are associated with NCDs (68) and rising levels of obesity (69). Interventions 
directed towards a global strategy on diet, physical activity and health featured 
significantly on the 2008 61st WHA agenda (70) on endorsing plans to prevent and 
control NCDs (71;72).  
 
There are no specific studies in Gauteng documenting the levels of physical activity of 
adults (56). Data emanating from other parts of the country show that most individuals 
did not engage in physical activity, particularly females and residents of rural areas (56). 
Twenty different cohort studies strengthen the claim that physical activity decreases the 
risk of DM by between 20-30% (51). Physical activity modifies the risk of DM through 
the prevention of obesity, but impacts on DM risk in the presence or absence of obesity 
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(51). These findings of reduced incidence of DM achieved without weight loss but with 
physical activity is substantiated by the Indian Diabetes Prevention Programme and the 
Da Qing IGT and Diabetes Study (73;74). Lifestyle modification has also been shown to 
be beneficial in BP management (75;76).  
 
Many studies have shown that the rapid urbanisation that the black population has been 
subjected to has resulted in an important change in their food consumption from a 
traditional high carbohydrate / low fat diet to a diet high in saturated fats and sugars (29). 
In the USA alone, poor diet and physical inactivity accounted for 20% of adult deaths in 
2000 (20). In South Africa, poor diet, defined by low fruit and vegetable intake, 
accounted for 3% of mortality and 1% of the 16.2 million attributable DALYs in 2000 
(77).  
 
2.3.7 The metabolic syndrome  
 
The MS cluster represents the most critical risk factors for the development of a 
myocardial infarction (MI) including DM, raised fasting plasma glucose, abdominal 
obesity, dyslipidaemia (defined in: Glossary of terms) and HPT (9). The diagnosis of the 
MS substantially increases the risk of DM, coronary artery disease (CAD) and premature 
mortality (78). The relationship between the MS and CVD, in some cases described as 
almost double the risk (79),  is well established irrespective of the definition used for the 
MS (80). Estimates suggest that 20 – 25% of the world‟s adult population have the MS 
(9). Those individuals with the syndrome are twice as likely to die from and three times 
as likely to have a MI or a cerebro-vascular accident (CVA) compared to those without 
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the syndrome (9). Additionally, those with the MS are five times more likely to develop 
DM (81). The clustering of diseases comprising the MS is considered to be the driving 
force of a new cardiovascular disease epidemic (9). In fact, the Strong Heart Study, a ten 
year longitudinal follow up of close to 4000 participants, found that the MS was highly 
associated with incident CVD in those known to have DM (82).  
 
Data from Finland found the prevalence of the MS to range from 4% in 24 year olds to 
25% in 39 year olds, with most of the increased prevalence attributed to obesity (83).  In 
the USA, the prevalence of being overweight or obese in children has tripled between 
1970 – 2000, with a corresponding increase in the MS in this young group (84). Other 
studies confirm these findings with the MS rates in adolescents at 12% using the 
modified National Cholesterol Education Programme Adult Treatment Panel III [NCEP 
(ATP) III] criteria and a prevalence of 10% in children aged 12-19 years of age from the 
National Health and Nutrition Examination Survey (NHANES) III cohort using the same 
criteria (85).  
 
The underlying causes of the MS remains unclear though insulin resistance (defined in: 
Glossary of terms) and central obesity have been significantly implicated (86;87). Insulin 
resistance results in hyperinsulinaemia and hyperglycaemia (Type 2 diabetes-[DM]) (9). 
Obesity is associated with insulin resistance and DM (9). Central obesity has been found 
to be more indicative of the MS than body mass index (BMI) measurements (88). Obesity 
contributes to HPT, hypercholesterolemia, low high density lipoprotein (HDL) and 
hyperglycaemia, and is an independent risk factor for CVD (86;89;90). Figure 1 reflects 
the complex interplay of these factors in the causation of MS.  
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Figure 2.1: The role of insulin resistance and obesity in the MS 
 
In South Africa, the burden of the MS seems to fall predominantly on black women. The 
NHANES III findings support the data that women, of African-American descent, have 
higher prevalence of the MS than their male counterparts with the prevalence in white 
males exceeding that of black males (91;92). The findings in Johannesburg are similar, 
with females having more severe MS (characterised by the presence of four or five 
criteria) and males having lower prevalence rates across both black and white populations 
(93).  
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2.4 SOUTH AFRICAN MANAGEMENT OF CHRONIC DISEASES 
 
Chronic cardio-metabolic diseases have historically been poorly managed in South 
Africa. Studies conducted in the Cape Peninsula reviewed the care received by 923 
patients with HPT and 455 with DM attending 18 community health centres (CHC) (94). 
There was 23% level of control among hypertensives and of those with diabetes as well, 
only 21% had a BP below the recommended level of 130/80 mmHg (94). In the DM 
patients, 42% had a random blood glucose above 11.1 mmol/ℓ and 76% had a HbA1c 
level ≥1% of the upper limit of normal (94). Numerous audits of patient folders have 
revealed that patients attending CHCs receive poor quality routine care for DM and HPT. 
The already poor levels of hypertensive and glycaemic control is exacerbated by the 
limited assessment of patients for target organ damage as reflected in their patient notes 
(36).  
 
Community health centres in Cape Town that had formed „chronic care teams‟ that meet 
regularly to discuss their goals and plan improvements through more structured and 
systematic approaches to patient care have showed vast improvement in the annual 
review of their diabetic patients in PHC (95).  Current management principles are 
targeted at prevention and early treatment to minimise the development of complications 
(96). Various other factors are implicated in the inadequate clinical examinations and 
care that these patients receive at clinic level. These include human resource issues, 
erratic drug supplies and complex tertiary cases from tertiary centres referred back to the 
clinic for management (94).   
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2.5 THE EPIDEMIOLOGICAL TRANSITION 
 
The term „epidemiologic transition‟ describes the change in disease patterns associated 
with economic development (4). There has been a drastic shift in mortality from 
infectious disease and malnutrition before the 1900s to CVD and cancer currently in most 
high-middle income countries (5). This can be attributed to the economic and social 
transformations resulting from industrial and technological revolutions that have 
transpired over the last two centuries (5).  
 
Developing nations have to contend with the emergence of chronic disease borne out of 
industrialization and the adoption of a Westernised lifestyle against a backdrop of poverty 
related illnesses (16). This double burden of disease is crippling to the economy and 
healthcare demands of the country. It is vital that such economies utilize their limited 
resources optimally and implement cost-effective health promotion interventions (16).  
 
Most of Africa is undergoing an epidemiological transition (35). By 2004, the World 
Bank still considered sub-Saharan Africa to be in the stage of pestilence and famine 
(Stage 1) despite CVD being the leading cause of death in those greater than 30 years of 
age in the region (5). South Africa appears to be approaching the age of degenerative 
man-made diseases (Stage 4)  characterised by „lifestyle changes in diet, activity levels, 
and smoking that set the stage for the emergence of atherosclerosis‟ (5). Current trends 
suggest that many developed countries are entering the unnamed Stage 5 of 
epidemiological transition characterised by epidemics of obesity and DM (5).  
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2.6 THE INDIVIDUAL IN THE CONTEXT OF THEIR ENVIRONMENT 
 
Given the massive burden of communicable and NCDs that the public health services 
contends with, the sustainability of interventions aimed at prevention and control of 
chronic diseases directed purely from the health system seems less likely. Tackling 
obesity and chronic diseases should become a „family matter‟ as the lifestyle changes 
would prove beneficial to the entire family especially considering the prevalence in adults 
and children alike. The health system has an important role in facilitating these processes. 
Figure 2.2 describes the interaction of the individual in the context of his environment.  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Understanding the individual in the context of their environment 
 
 
 
 
 
 
Health services Community Family INDIVIDUAL 
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2.6.1 The contribution of the individual to his disease 
 
Health reform post apartheid has seen increases in the numbers of peripheral clinics and  
screening programmes reaching the masses and yet disease rates remain high (50).  Poor 
adherence to treatment is largely responsible for uncontrolled HPT (97) but the factors 
implicated are easily applicable to most chronic diseases and are described in Table 2.1. 
 
Table 2.1: Obstacles to adherence 
Treatment characteristics Patient and illness characteristics 
 Long duration of therapy 
 
 Asymptomatic nature of the condition 
leaves people feeling that they are not ill 
 Complicated regimens  
 
 Chronic conditions require constant 
attention 
 Expensive medications  There are no immediate consequences of 
stopping, e.g. one does not feel sick 
 Side-effects of medications   Social isolation 
 Lack of specific appointment times  Disrupted home situation 
 Long waiting period at clinic or office   Psychiatric illnesses 
 Lack of consistent and continuous 
primary care  
 
 Instructions not understood   
 Organic brain syndrome (e.g. memory 
deficit) 
 
 Medicines not available  
Source: South African Hypertension Guideline 2006 (97) 
 
Much of the answer lies with the individual. Attaining optimal disease control hinges on 
the individual in the community having an understanding of the disease (50). Patients 
understanding their disease processes allows them to assess their risk of disease, 
motivates them to seek appropriate treatment and, to some degree, to take control of the 
disease in their lifetime (50;98;99).  
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The point of educating patients about their disease is not to increase their knowledge 
concerning the disease but rather to adapt the management and control of the disease to 
the constant changes occurring in the patients‟ life (100). While this data refers 
specifically to the self-management of DM, the principle is applicable to all diseases of 
lifestyle.   
 
Another important concept that emerges with progressive urbanisation and 
Westernisation of lifestyles is that of affluence. Affluence has rendered the higher-
income black South African more susceptible to MI than the high-income white or other 
non-black counterparts presumably due to being in a different stage of the 
epidemiological transition (35).  
 
2.6.2 The role of the community  
 
Community resources serve as an invaluable adjunct to health care services in the 
management of chronic diseases. Patients spend most of their time within a community 
and not linked to a health system. Thus, communities are ideally placed to raise the 
profile of diseases, generate awareness about their associated risk factors and reduce 
stigma through involvement of leaders, non-governmental organisations and local support 
groups (101).  
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In fact, the large numbers of PHC clinic visits related to DM in Gauteng for 2006/07 (472 
847 visits in total) were attributed in part to the 73 support groups for DM in the province 
(56). The community thus plays a vital role in health promotion and prevention 
campaigns and training of community health workers (101).  
 
2.6.3 The impact of health services 
 
Given the overwhelming burden of infectious diseases in both low-income and middle-
income countries, it is not surprising that the chronic diseases are often treated as serial 
acute episodes and not with a continuum of care (102). The repeated management of the 
acute phase of chronic diseases may improve to the detriment of the prevalence of the 
disease resulting in soaring expenses due to the increased burden of disease (102). 
Interventions targeting chronic diseases are highly dependent on well functioning health 
systems as they require long term co-ordination and inter-sectoral collaboration across a 
continuum of care (33). 
 
South Africa is better resourced and has a better health structure than anywhere else in 
sub-Saharan Africa and it is thus conceivable that impetus can be given to these 
interventions (53). Feasible interventions such as optimising blood glucose levels, 
adequate BP control and simple measures such as foot care have been shown to be highly 
cost-effective (53).  
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However, the reality is that many South African studies have reported sub-optimal HPT 
and DM control, infrequent examinations for complications despite their high rate of 
occurrence and poor supplies of lipid lowering medication in the PHC facilities (53). 
 
When considering individual diseases, the high mortality comparative to the prevalence 
of DM might well reflect the sub-optimal level of care by health services in this country 
(53). A Kwa-Zulu Natal study also showed that patients who were informed by clinic 
staff of their blood glucose levels had better DM knowledge possibly translating to 
improved self management (50).  Patients receiving counselling at the PHC on diet, 
exercise and their medication had much better knowledge on the disease and its 
management resulting in better glycaemic control (50).  
 
The situation appears to be similar for HPT control. The HiHi Study showed that only 
26% of patients were informed of their BP readings at their last visit and on average, only 
a single change was made to their HPT medication in the last year despite their control 
being far from adequate (58). Failure to inform patients of their BP measurements had 
been shown to be associated with poor compliance and having a negative influence of 
patient empowerment (58). Problems associated with poor HPT control are still 
compounded by inadequate medication stocks at PHC level (58). These inherent flaws in 
the health care system sends a potent message to patients and their families that HPT 
control is not important (58).  
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Interestingly, the HiHi Study also showed that patients receiving private health care had 
better BP control than those attending PHC facilities despite those in private having a 
higher prevalence of DM and being more obese (103), a finding that reaffirms the 1998 
SADHS (104). In many ways, this serves as an indictment on the quality of care of 
services provided in the public sector.  
 
2.7 DEVELOPING NON-COMMUNICABLE DISEASE SURVEILLANCE  
 
An operational NCD surveillance system, similar to programmes conducted with 
communicable diseases, is an integral cog in the public health response to NCDs as 
information generated informs decision-making and priority setting (12).  
 
The basic principle is that countries are able to collect and integrate data at the most basic 
level, and allow for more sophisticated information systems as resources allow (22). The 
WHO STEPwise chronic disease risk factor surveillance approach argues that NCD 
surveillance should be an essential national public health function (12). In Gauteng , the 
planning for the implementation of this approach began in 2006 (56) with the focus now 
being shifted to setting up surveillance systems for the continuous monitoring and 
evaluation of NCDs.  
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Figure 2.3 describes the sequential approach of STEPS based on a of information 
gathering (Step 1), acquiring simple anthropometry (Step 2) and only then drawing blood 
for biochemical assessment (Step 3) (12).  
 
 
Figure 2.3: The concept of the STEPwise approach 
 
By standardising the data collection tools, data collected within a country, and indeed, 
between countries become comparable (12). This ideal forms the basis of this research. 
This pilot study concentrates on the core modules (12) of the WHO STEPwise.  
 
Many factors implicated in the development of NCDs are not amenable to change (e.g. 
genetic). The emphasis of a surveillance programme should be placed on those core risk 
factors that are amenable to modification (105;106) and can provide measurable 
successes through intervention. This makes sense considering that inappropriate diet, 
physical inactivity and concurrent tobacco use together explain about 75% of CVD (107).  
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2.8 SUMMARY OF THE CHAPTER 
 
The global prevalence of cardio-metabolic diseases is increasing with much of the burden 
attributable to urbanisation and poor lifestyle choices: physical inactivity and unhealthy 
diets. Low-income and middle-income countries face increasing cardio-metabolic disease  
associated morbidity and mortality placing huge demands on the health systems already 
overrun with the competing needs of infectious diseases and maternal and child health. In 
South Africa, optimal management of these diseases (particularly DM, HPT and obesity) 
extends beyond the disease with individual and health system factors impacting 
considerably of delivery and use of services. Surveillance of NCDs plays an integral part 
of the national NCD programme. Information generated guides policy development and 
tailors services to the specific needs of the community.  
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CHAPTER 3 
STUDY METHODS AND MATERIALS 
 
The study methodology was defined by the aim and objectives of the study. The chapter 
describes the study design, setting and sampling strategy. The data collection, 
management and measurement are discussed followed by the analysis plan.  
 
3.1 STUDY DESIGN 
 
A community based cross sectional survey was conducted. 
 
3.2 STUDY SETTING AND SCOPE 
 
3.2.1 Study setting 
 
Soweto is the largest township in sub-Saharan Africa with the highest concentration of 
black Africans on the continent representing the major black ethnic groups in South 
Africa (34). The study population included the residents of Chiawelo, a suburb in Soweto 
located in Region D of the Johannesburg Health District (indicated by the arrow in Figure 
3.1).  Chiawelo is representative of various ethnic (Nguni, SothoSwana, Tshangaan and 
Venda speaking) and socio-economic groups found in the Johannesburg Health District, 
thus represents a homogenous black population with heterogeneous ethnicity.   
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Figure 3.1: Regional map of Johannesburg indicating Chiawelo 
 
The Chiawelo CHC which caters for this population ranked second in the Johannesburg 
Health District with regard to the number of diabetic patients seen according to the 
District Health Information System (DHIS) data from April 07– March 08. Additionally, 
the community of Chiawelo was selected given their high numbers of diabetic patients 
which translates to increased disease prevalence in the area (108).  
 
3.2.1 Scope 
 
The study involved primary data collection.  
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3.3 STUDY POPULATION AND SAMPLING 
 
3.3.1 Study populations  
 
The study population comprised residents of the Chiawelo community that had been 
resident for 5 years or more. Residents aged 18 years or older during the study period 
were included in the study.  Those younger than 18 years of age, had refused blood 
testing or had dementia or severe psychiatric illness were excluded.  
 
3.3.2 Sample size calculation 
 
STATCALC was used to calculate the sample size (109). A sample size of 288 was 
calculated as appropriate for this study using a confidence interval of 95%. The 
prevalence of cardio-metabolic diseases in South Africa varies between 1 – 30%. In light 
of this prevalence, a pre-test probability of 25% was used with a worst acceptable rate at 
20%.   
 
As the exact prevalence is unclear, the decision was made to over-sample the population 
as this would additionally increase the generalizability of the study results.   The 20% 
increase on the initial calculated sample size (n=345) still had randomly selected 
participants using the cluster sampling technique. The final sample size was 337, as nine 
participants were excluded based on the exclusion criteria described in Section 3.3.1: 
Study populations.  
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3.3.3 Sampling strategy 
 
 A cluster sampling technique was used for this study. The study sample represented a 
single stratum with clusters. Second stage sampling of people from the clusters was then 
performed (multi-stage cluster sampling). The schema for the clustering and selection 
process was adapted from a previous study conducted in the area (Appendix A: Sampling 
strategies) (110). Using a map, Chiawelo was divided into 20 clusters, five of which were 
randomly chosen for the study (Figure 3.2). Seventy subjects were chosen from each of 
these five clusters.  
 
A point marked X was placed on the map. The research assistants (RA) started at this 
point X and then selected the first yard on the left side of the street. They then went to 
every third yard till 70 participants were recruited per each of the five clusters. RAs 
employed were trained in the above technique. If no one was available at a chosen house 
or if the occupant refused participation then three yards from that point was calculated to 
maintain the sampling strategy.  
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Figure 3.2: Map of Chiawelo indicating recruitment sites 
 
3.4 STUDY PERIOD 
 
The study ran from 18 May – 5 June 2009. The chosen study period had 15 full working 
days and did not coincide with any public or religious holidays. Data was collected 
between the hours of 8am – 4pm and participants were not recruited on weekends.  
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3.5 DATA COLLECTION  
 
 
3.5.1 Data collection  
 
 
The principal investigator (PI) and five research assistants (RA) collected the primary 
data. Once written informed consent was obtained, the questionnaires were completed by 
the RAs at the participants‟ home. The time required to complete the questionnaire was 
no more than 30 minutes. The participants‟ were then brought to the Changing Diabetes® 
Bus where the anthropometric measurements and blood drawing was done.  The 
Changing Diabetes
®
 Bus is a mobile clinic operated by Novo Nordisk in collaboration 
with the Gauteng Department of Health (Figure 3.3) that provides free screening for DM, 
HPT and anthropometric measurements (height, weight and waist circumference [WC]).   
 
 
 
Figure 3.3: Participants outside the Changing Diabetes
®
 Bus 
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3.5.2 Measurement tools  
 
Various documents were developed to facilitate the ethical conduct of the study and data 
collection (Appendix B: Measurement tools):  
Tool 1: Patient information sheet  
Tool 2: Patient informed consent  
Tool 3: Patient questionnaire   
 
3.5.2.1 Validity of measurement tools 
The tools used in this study were adapted from a 2008 study conducted by the 
Department of Community Health (108). The patient questionnaire also incorporated the 
Type 2 diabetes risk assessment form developed by the Finnish Diabetes Association 
(111). 
    
3.5.2.2 Reliability of measurement tools 
The reliability of the tools was verified through a pilot study (Section 3.8: Pilot Study).  
 
3.5.3 Reproducibility of measurements   
 
Training of the RAs served to reduce the likelihood of intra-operator variability. The RAs 
selected were fluent in the local languages and conducted structured interviews in 
participants‟ home languages. All measurements were conducted consistently by the 
same individuals (intra-operator variability). Each measurement was taken twice to 
reduce the likelihood of inter-operator variability.  
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The Bland-Altman analysis is a methods comparison approach that assesses the 
agreement between two methods of clinical measurement (112). The mean ( ) 
differences and the standard deviation (SD) of differences between the two measurements 
were calculated and the limits of agreement represented by: Limits of agreement =  + 
2SD. The inter-operator variability was calculated (113) and is presented in Table 3.1.  
 
Table 3.1: Inter-operator variability for measurements 
   Limit of agreement 
Variable   SD Upper Lower 
Waist (cm) -0.09 0.56 1.03 -1.21 
Weight (kg) 0.75 0.46 0.99 -0.84 
Height (mm) 0.00 0.00 0.01 -0.01 
SBP (mm/Hg) 5.33 15.90 37.13 -26.46 
DBP (mm/Hg) 2.66 14.06 30.77 -25.45 
 
Patients with persistently high BP recordings were asked to return the next day to repeat 
the measurement and verify the initial figures obtained. Appropriately sized 
sphygmomanometers cuffs were selected according to the size of the patients‟ arm. Blood 
drawings were conducted after the BP measurements to avert the stress of the drawing 
impacting on the BP measurement.  
 
3.6 DATA MANAGEMENT AND MEASUREMENT 
 
Data was entered into Microsoft Excel 2003 and transferred to Stata release 10 (114) for 
statistical analysis. The data were checked for errors by the PI. In addition, 15 
questionnaires from each week were randomly selected, and data entry was double-
checked in each field. 
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Data from the questionnaire (Appendix B: Measurement tools) was categorized into two 
sections, as described below and is followed by a detailed description of the individual 
variables. 
 
1. Socio-demographic factors - examined factors such as the age, educational level and 
socio-economic status (SES) of the participants. It also addressed the impact of fresh 
fruit and vegetable consumption and levels of physical activity by measuring energy 
expenditure.  
2. Clinical factors – assessed the anthropometric (e.g. height, weight), clinical (e.g. BP, 
BMI) and biochemical measurements (e.g. HbA1c levels) of participants. The section 
included previously reported histories of DM or HPT.  
 
3.6.1 Description of variables 
 
This section describes how the data was organized to meet the objectives of the study. 
Table 3.2 describes the variables used in the bivariate and multivariate analyses. The 
table describes the type of variable, unit of measurement and generation of variables. The 
variables generated to meet the objectives are then described.   
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Table 3.2: Description of variables used in the analyses 
 
Variable Type (Abbreviation) / Description  
Socio-demographic   
Gender Categorical Male or female 
Age 
(years) 
Continuous  
Non-normal 
Calculated from South African ID document and presented 
as integers. Range: 18-93. 
Marital status Categorical 
 
Six level variable: single, married, widowed, divorced, 
cohabit, other. 
Education Categorical Six level variable dichotomised into < Grade 12 and  
≥ Grade 12. 
Work Categorical Eight level variable coded into four levels: unemployed, 
employed, students, retired. 
Socio-economic status Continuous 
Non-normal 
(SES). Scale derived from Asset Index Score used in a 
previous South African study assessing chronic diseases 
and poverty (115).  A four point Likert scale was used to 
score each of the 13 items. (13-items, Cronbach‟s  =0.74). 
Fruit and vegetable 
consumption 
Categorical Combining two variables: fruit consumption/wk, vegetable 
consumption/wk. Three level variable generated: 
consumption – never, 1-4 days/wk, 5-7 days/wk. 
Alcohol use Categorical Self reported alcohol use by participants. Two level 
variable: yes, no. 
Tobacco use Categorical Self reported tobacco use by participants. Two level 
variable: yes, no. 
Energy expenditure 
(kcal) 
Continuous 
Non-normal 
Self reported duration of mild, moderate and intense 
activity per week (116;117). Range: 0 – 61128. 
Family history Categorical Self reported history of DM and/or HPT in parents, siblings 
or grandparents. Two level variable: yes, no. 
Social grants Categorical Three level variable: child, disability, old age. 
Clinical   
Waist circumference 
(cm) 
Continuous 
Normal 
(WC). Average of two readings taken using paper tape 
measures. Range: 58 – 145. 
Height  
(mm) 
Continuous 
Normal 
Average of two readings taken using a manual, vertical 
scale. Range: 115 – 190. 
Weight 
(g) 
Continuous 
Normal 
Average of two readings taken using an electronic scale 
calibrated daily. Range: 45 – 141.  
Body mass index  
(kg/m
2
) 
Continuous 
Non-normal 
(BMI). Calculated using the Quetelet Index [BMI = weight 
(kg) / height(m)
2
](10). Range: 17 – 55.  
Previous history of HPT Categorical (Prev. diag. – HPT). Self reported HPT by participants. 
Systolic blood pressure 
(mm/Hg) 
Continuous 
Normal 
(SBP). Average of two readings taken using a 
sphygmomanometer calibrated daily. Range: 93 – 238. 
Diastolic blood pressure 
(mm/Hg) 
Continuous 
Normal 
(DBP). Average of two readings taken using a 
sphygmomanometer calibrated daily. Range: 57 – 144.  
Previous history of DM Categorical (Prev. diag. – DM). Self reported DM by participants. 
Glycated haemoglobin 
(%) 
Continuous 
Non-normal 
(HbA1c). Biochemical measurement of glycaemic control 
over the preceding 2-3 months (1). Range: 4.4 – 15.3.  
Metabolic syndrome Categorical (MS). Defined using the IDF criteria (9). 
 
44 
 
3.6.1.1 Socio-demographic variables  
 
Gender 
The analysis was stratified by gender. This is because the literature points to appreciable 
differences in chronic disease epidemiology between females and males.  
 
Education 
Education was stratified into those with < Grade 12 and those with ≥ Grade 12. Grade 12 
represents a landmark educational level in the South African education system and was 
hence used as a cut-off point in this study. Learners who successfully complete Grade 12 
have the potential to enter a Bachelors degree programme at a university, and can thus 
pursue tertiary education (118). 
 
Socio-economic status  
The socio-economic questionnaire was based on a validated questionnaire used in a 
Soweto study with a similar setting to this study (110). The questionnaire collected 
information on various topics such as: housing, access to electricity, indoor water source 
and toilets, material possessions (such as television sets, radio, music system, video 
machine, fridge, washing machine, microwave, land-line telephone, motor vehicle), the 
number of residents and household income. An asset indicator score (115) was then 
calculated using a 4 point Likert scale for each of the 13 variables mentioned. The asset 
indicator score was then used to divide the subjects into quartiles ranging from lower to 
higher SES.    
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Energy expenditure 
A questionnaire (long version) designed and tested by the „International Consensus 
Group for the Development of an International Physical Activity Questionnaire‟ was used 
to collect information from the subjects about their physical activities (116;117). The 
questionnaire had been tested in 12 countries and found to have acceptable measurable 
properties for monitoring of physical activity among participants (18 to 65 years old) in 
diverse settings (119). The questionnaire was designed to collect self-reported 
information on occupational, household and garden/yard work, transportation and leisure-
time physical activities during the previous 7 days.  Computation of the total scores 
requires summation of the duration (in minutes) and frequency (days) of walking, 
moderate-intensity and vigorous-intensity activity. A MET-minute is computed by 
multiplying the MET score (METS are multiples of the resting metabolic rate) by the 
duration of minutes, the activity is performed (119).   
  
Kilocalories may then be calculated from MET-minutes using the following equation: 
Kcal = MET-min X (weight in kg/ 60 kg) 
 
Social grants 
Social grants, in particular disability and child support grants and old age pensions, are 
discussed in this study in lieu of the large percentage of the South African population 
relying on these remittances as their sole source of income. Close to 15 million South 
Africans obtain social grants from the government, 10 million of whom are children who 
receive the child support grant, linked to school attendance (120).   
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3.6.1.2 Clinical variables 
 
Waist circumference   
It was measured in the horizontal plane at the level of the natural waist (narrowest part of 
the torso) as seen from the anterior aspect of the body (121).  
 
Height 
Standing height was measured using a fixed stadiometer to the nearest mm.  
 
Weight & body mass index  
Weight (in grams) was measured using the same scale for all subjects and the BMI was 
calculated from the height and weight. The BMI is a commonly used indicator to assess 
the nutritional status of adults. It correlates highly with adiposity. Body Mass Index was 
calculated from the height and weight using following formula (10): BMI = Weight in 
kg/ (Height in m)
2
  
 
Subjects were then classified into following weight categories (defined in: Glossary of 
terms) (11):  
 Under-weight (< 18.5)  
 Normal-weight (18.5 to 24.9)  
 Over- weight (25 to 29.9) and  
 Obese (30 or more). 
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Diabetes mellitus & hypertension     
The primary outcome measure remained the presence of disease. Prevalence rates for 
HPT and DM were calculated by adding the self-reported cases to the new cases 
identified by measurement in the study. Self-reporting of HPT and DM was used to 
interpret disease control parameters and levels of undiagnosed disease in the study 
population. The information gauged from those reporting yes to having the disease were 
used as a proxy to determine the control of the disease. Similarly, those who reported no 
to having a disease served as a proxy for the numbers of undiagnosed cases of the disease 
in the study population.  
 
 Diabetes mellitus 
The analysis of HbA1c was conducted through the National Health Laboratory Service 
(NHLS) laboratories which are accredited by the South African National Accreditation 
System (SANAS). The accreditation involves assessing the implementation of quality 
standards as well as the competence of the laboratory to perform designated tests. This 
ensures that tests performed in these laboratories are comparable to the same test 
performed anywhere else in the world using the same methodology. 
 
The Cobas Integra analyser (Roche, South Africa) was used for analysis of HbA1c 
specimens. This is a completely automated system that determines HbA1c using whole 
blood samples. The system is designed to immediately flag blood samples unsuitable for 
analysis (clotted) while internal quality control software programmes monitor precision 
and accuracy to ensure reliable results.(122) 
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Those individuals with HbA1c results were considered in this analysis. Individuals with 
outstanding results were excluded. The HbA1c levels were categorised according to the 
American Diabetes Association (ADA) guidelines (defined in: Glossary of terms)  (1). 
The ADA advocates the use of HbA1c for the diagnosis and management of DM as it is 
more convenient than tests requiring fasting samples, has greater pre-analytical stability 
and is subject to less day-to-day fluctuations during periods of stress and illness (1). The 
Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) does 
not advocate the use of the HbA1c for diagnosing DM, mostly because of limited capacity 
to perform the test in some parts of the public sector, increased costs and because the test 
may not be useful in the presence certain co-morbidities (e.g. chronic malaria, iron 
deficiency anaemia) (123;124). 
 
Despite these valid reservations, HbA1c was used in this study as it allowed for ease of 
collection and based on the reasons postulated by the ADA. A bivariate variable was 
generated using these guidelines and risk factors associated with the development of 
disease was assessed in those with the disease compared to those without. This variable 
was used in the prevalence, bivariate and multivariate analyses of the DM. 
 
Table 3.3 describes the levels of DM disease control designated in accordance with the 
ADA classification using HbA1c (1). This was used to classify the disease control in 
individual participants based on their HbA1c results.  
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Table 3.3: Level of DM disease control described by HbA1c levels 
ADA classification HbA1c level Level of control 
Normal  < 5.7% Good 
Impaired glucose tolerance  5.7 – 6.4% Sub-optimal 
Diabetes mellitus ≥ 6.5% Poor 
 
 Hypertension  
The SBP and DBP levels were categorised using The Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC7) definition of HPT (defined in: Glossary of terms) (6). The SBP and DBP 
categories described were combined to generate a bivariate variable of participants with 
HPT and those without. The risk factors associated with the development of disease was 
assessed using this generated variable.   
 
Table 3.4 describes the levels of HPT disease control designated in accordance with the 
JNC7 classification (6). This was used to classify the disease control in individual 
participants based on their BP recordings at the time of the interview.   
 
Table 3.4: Level of HPT disease control described by BP readings  
BP classification SBP (mmHg) DBP (mmHg) Level of control 
Normal  <120 and < 80 Good 
Prehypertension 120 - 139 or 80 - 89  
Stage 1 hypertension 140 - 159 or 90 - 99  
Stage 2 hypertension ≥ 160 or ≥ 100 Poor 
 
Sub-optimal 
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Obesity 
Body weight was categorized according to the WHO Global Database on BMI (11). A 
bivariate variable was generated comparing obese individuals (BMI ≥ 30 kg/m2) with the 
rest of the study population. This variable was used in the prevalence, bivariate and 
multivariate analyses of the obesity.  
 
Metabolic syndrome  
The primary outcome measure was the diagnosis of MS. This was generated 
independently by gender to accommodate for the variation in WC criteria between males 
and females (9). A bivariate variable was generated consolidating the male and female 
information but differentiating those with the syndrome from those without using the IDF 
definition of the MS (defined in: Glossary of terms) (9). The IDF criteria were 
specifically used for this study as the definition tends to result in higher prevalence rates 
of the syndrome than other definitions (125), provides clear guidelines for identifying at 
risk populations worldwide (29) and uses specific WC cut-off levels for males and 
females in different ethnic groups (126). The IDF criteria for the diagnosis of the MS 
were modified for the purposes of this study. Firstly, HbA1c results were used as a 
surrogate for fasting plasma glucose samples. This was done to facilitate ease of 
collection and given the financial and human resources constraints of the project. The use 
of HbA1c was deemed to be acceptable in the diagnosis of DM in keeping with the 
current ADA guidelines (1). Secondly, blood samples collected for lipid profile analysis 
were incorrectly stored, and were unable to be analysed. Thus, the diagnosis of the MS is 
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based on the criteria defining waist circumference, HPT and DM using HbA1c as a 
surrogate.  
 
3.7 DATA ANALYSIS 
 
Stata 10 (114) was used to perform bivariate and multivariate regression analysis. 
Descriptive statistics and multivariate regression was used to answer the study objectives. 
Statistical tests used in the analysis and their indications are described in Table 3.5. The 
differences were considered to be statistically significant if p<0.05. All analyses 
accounted for the effects of clustering in the study design. 
 
Table 3.5: Indications for statistical tests  
 
Dependent 
variable 
Independent 
variable (IV) 
Distribution Test Example 
Categorical 1 IV with 2 levels 
(independent group) 
 Chi-square test Education 
and gender 
Continuous One sample,  
one variable  
Normal Mean, standard 
deviation (SD) 
WC 
 Non-normal Median, inter 
quartile range 
(IQR) 
Age  
 1 IV with 2 levels 
(independent groups) 
Normal Student‟s t-test WC and 
gender 
 Non-normal Wilcoxon-Mann 
Whitney test 
BMI and 
gender 
 1 IV with 2 or more 
levels  
(independent groups) 
Non-normal Kruskal-Wallis  Age and 
work  
Categorical or 
continuous  
1 IV with 2 or more 
levels 
Normal or 
non-normal 
Multivariate 
regression 
HPT with 
age and 
gender 
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Distribution of the variables was assessed. Data were assessed according to their 
distribution (as described in Table 3.5). Chi-square testing (X
2
) was used to test the 
association between categorical variables in the bivariate analysis.  
 
For the parametric data, Student‟s t-tests were performed for the analysis of continuous 
variables and described in terms of means and SD. For the non-parametric data, the 
Wilcoxon-Mann Whitney test was used for continuous data and results were expressed 
with medians and inter-quartile ranges (IQR). Kruskal-Wallis testing was performed 
when several independent groups were being compared to a continuous variable. This 
provided evidence of a difference between the groups. When a significant value was 
found, the kwallis2 command was used to perform post-hoc paired comparison testing to 
determine which groups were different. 
 
Some variables were dichotomized to simplify the statistical analysis and allow for ease 
of interpretation and presentation of results. However, it was appreciated that in 
dichotomizing variables, much information could be lost, so the statistical power to detect 
a relationship between the variable and outcome is reduced. One of the variables 
dichotomized was the education level into below Grade 12 and  Grade 12.  
 
All factors found to be significant in the bivariate analysis at p-values <0.1 were 
considered for the multivariate logistic regression analysis. Stepwise backward 
multivariate logistic regression was performed and non-significant factors were 
sequentially removed from the model. Explanatory variables with consistent p-values 
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<0.05 remained in the model. The multivariate models found to be significant were tested 
for multicollinearity (this is multiple regression where the predictor variables themselves 
are highly correlated). As the degree of multicollinearity increases, the regression model 
estimates of the coefficients become unstable and the standard errors for the coefficients 
can possibly be inflated. Variance inflation factor (vif) specific to survey data was used to 
test for this.  
 
Various associations between factors purported to predispose to the MS were assessed by 
Spearman‟s correlation and the relationship quantified by linear regression. The strength 
of the associations between various factors was tested by residual analyses. This tested 
the model for normality, common variance, linearity and assessment of outliers as 
described below: 
 
 Normality:  
The distribution of the data was tested using the residual values (difference between the 
observed and predicted values in the model) and the studentized residual values (residual 
value divided by the standard error/standard deviation of the value). If the residual is 
normally distributed, an increase (or decrease) in one variable would results in a 
proportional change in the second variable (e.g. a unit increase in BMI would result in a 
unit increase in the SBP). The Shapiro-Wilk test was used to statistically test the 
distribution of the data.  
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 Common variance and linearity: 
 Plotting the studentized residuals against the observed values should show a random 
pattern in the residuals. This assesses linearity and tests for homogeneity of variance. The 
Breusch-Pagan test was used to test for heteroskedasticity in the linear regression model 
testing whether the estimated variance of the residuals (e.g. the difference between the 
observed and predicted values in the SBP from a regression) are dependent on the values 
of the independent variables (e.g. BMI) 
 
 Outliers & Cook‟s distance:  
These tests were conducted to assess for outliers (variables with large residual values). 
Values identified as outliers by Cook‟s Distance (which combine the leverage and 
residual values) would be deleted and the model reanalyzed. When plotting the leverage 
against the normalized residuals squared, points above the horizontal line have higher 
than average leverage; points to the right of the vertical line have larger than average 
residual values (Figure 3.4) (e.g. the outliers of SBP in the above regression model would 
be removed and the model reanalyzed). If the same strength of association is yielded 
irrespective of removal of the outliers, then the outliers had no impact on the initial model 
and the finding (e.g. a unit increase in BMI would result in a unit increase in the SBP) is 
generalizable.   
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Figure 3.4: Diagram showing values identified by Cook’s distance 
 
3.8 PILOT STUDY 
 
The questionnaire was piloted among ten staff members of the University of the 
Witwatersrand School of Public Health prior to the commencement of the study. The 
findings of the pilot study revealed possible limitations to the study, and based on these 
findings, the tools utilized were modified accordingly.  
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3.9 ETHICS 
 
The study was submitted to the Committee for Research on Human Subjects of the 
University of the Witwatersrand, Faculty of Health Sciences, for consideration (Ethics 
number: M090831) (Appendix C: Permissions). The study was conducted in an ethical 
manner and information obtained was treated with the strictest of confidence. Written 
informed consent was obtained from the participants. Disease information pamphlets 
were distributed to the participants as they awaited clinical assessment. Participants 
received immediate referral to their local clinic if their clinical assessments warranted 
this. These documents are presented in Appendix D: Patient documents.   
 
The study was conducted with the permission of the Non-communicable Disease 
Directorate: Gauteng Department of Health as service delivery project to the province as 
part of the Registrar training programme. The findings of the study could potentially 
influence current NCD policy.  
 
3.10 SUMMARY OF THE CHAPTER 
 
This study was a community based cross sectional survey conducted in Chiawelo, 
Soweto in the Johannesburg Health District. The study describes the baseline descriptive 
socio-demographics of the community. Multiple regression models were performed to 
identify factors associated with disease causation. Ethical approval was obtained from the 
Committee for Research on Human Subjects at the University of the Witwatersrand.  
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CHAPTER 4 
RESULTS 
 
This chapter outlines the main results of the study. Demographic characteristics of the 
study population are presented, followed by data on the individual cardio-metabolic 
diseases. Associations between the risk factors are then explored. Finally, the MS is 
briefly discussed.  
 
4.1 SOCIO-DEMOGRAPHIC FACTORS 
 
 
The demographic characteristics of the study population are set out in Table 4.1. The 
study comprised 337 participants.    
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Table 4.1: Demographic characteristics of the study population (n=337) 
Variable Total Female Male  
    n=337 (%) n=213 (%) n=124 (%) p-value 
Age
#
  44 (30-56) 45 (32-57) 39 (26-56) 0.033* 
Marital Single 138 (41) 83  (25) 55  (16) 0.024* 
status Married 127 (38) 76  (23) 51  (15)  
  Divorced  19   (6) 14  0(4) 5  0(1)  
  Widowed 37 (11) 32  (10) 5  0(1)  
  Cohabit 15   (4) 8  0(2) 7  0(2)  
  Other 1   (0) 0  0(0) 1  0(1)  
Education < Grade 12 195 (59) 136  (41) 59  (18) 0.004* 
   Grade 12 139 (41) 75  (22) 64  (19)  
Work Unemployed  168 (50) 120  (36) 48  (14) 0.001* 
  Employed 88 (26) 42  (12) 46  (14)  
  Student 19   (6) 9  0(3) 10  0(3)  
  Retired 62 (18) 42  (12) 20  0(6)  
 SES
#
  44 (30-56) 45 (32-57) 39 (26-56) 0.115* 
Social  Yes 106 (31) 88  (27) 18  0(5) <0.001* 
grants         
*statistically significant 
#
 median and (IQR) 
 
 
        
4.1.1 Gender 
 
The study comprised 337 participants: 213 female (63%), 124 male (37%).  
 
4.1.2 Race 
 
Most study participants were black (336/337) with only one coloured female.  
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4.1.3 Age 
 
The median age of participants was 44 years (IQR 30-56). The ages ranged from 18 to 93 
years. The age distribution was right skewed and platykurtic. Figure 4.1 describes the age 
distribution of the population sample by gender: the female age distribution was 
platykurtic while the males appeared bi-modal. While age and gender were significantly 
associated (p=0.033), there was no evidence of collinearity.  
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Figure 4.1: Age distributions by gender 
 
 
 
4.1.4 Marital status 
 
There was a statistically significant association between marital status and gender (chi 
square test, p=0.024). Specifically, widowed participants were identified as highly likely 
to be female than male (OR 4.24, 95% CI 1.56-11.55). 
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4.1.5 Education 
 
The majority of participants did not complete high school (124/334, 37%).  Only 26% 
(88/334) had matriculated. Three percent (9/334) had no prior education.  
 
4.1.6 Work 
 
The association between gender and work remained significant when adjusted for age 
(p=0.017). The statistically significant relationship between age and work (Kruskal-
Wallis, p<0.001) was then further described by gender. Among genders, the following 
relationships showed significant differences in median ages (kwallis2):  
 Unemployed and students (Female: p<0.001, male: p<0.001) 
 Employed and students  (Female: p=0.001, male: p<0.001) 
 Retired and unemployed (Female: p<0.001, male: p<0.001) 
 Retired and employed  (Female: p<0.001, male: p<0.001) 
 Retired and students  (Female: p<0.001, male: p<0.001) 
There were no significant differences in the ages between those employed and those 
unemployed.  
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4.1.7 Social grants  
 
Females were mostly dependant on the child support grants (47/88, 53%) and the median 
age of the women accessing these grants was 32 years (IQR 29-40). Most males 
accessing grants accessed the old age pensions (16/18, 89%). This was at the median age 
of 69 years in males (IQR 68-78) and 66 years (IQR 64-72) in females. 
 
The association between social grants and gender was significant when adjusted for age 
(p<0.001). Among the genders, the following relationships had significant differences in 
median ages (kwallis2):  
 Child support and old age (Female: p<0.001)  
 Child support and disability (Male: p=0.012) 
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4.2 CARDIO-METABOLIC DISEASES AND ASSOCIATED RISK 
FACTORS  
 
In this section, the cardio-metabolic diseases and associated risk factors individual risk 
factors in the study sample will be described.    
 
4.2.1 CARDIOVASCULAR RISK FACTOR PROFILE 
 
Table 4.2 shows the CVD risk factor profile of the study population stratified by gender. 
Thirty eight percent (38%) of females had reported a previous history of HPT with 24% 
in males (30/124) (chi square test, p=0.031). Females had a markedly elevated BMI level 
compared with males (Mann-Whitney, p<0.001). Though not statistically significant, 
both genders had elevated mean systolic BP (SBP) and diastolic BP (DBP). There was a 
significant difference between HbA1c levels in males and females (p<0.001) and both 
these values were within normal limits. 
 
Table 4.2: Cardiovascular risk factor profile (n=337) 
   Female    Male  
Risk factors n = 213 (%) n = 124 (%)  p-value 
Socio-demographic       
Age #  45 (32-57) 39 (26-56) 0.032* 
Uses tobacco 34 (10) 18 0(5) 0.724* 
Clinical      
BMI # 31 (27-36) 25 (21-28) <0.001* 
Prev. diag. - HPT  81 (24) 30 0(9) 0.031* 
SBP ## 143 (24) 148 (21) 0.070* 
DBP ## 89 (14) 91 (15) 0.333* 
Prev. diag. - DM 20 0(6) 17 0(5) 0.439* 
HbA1c
#  5.5 (5.2-5.9) 5.3  (5.1-5.6) <0.001* 
* statistically significant 
##
 mean and (SD)  
#
 median and (IQR) 
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4.2.2 DIABETES MELLITUS 
 
Figure 4.2 describes the self reported prevalence of DM. Those participants without 
HbA1c results were excluded (11/337, 3%). From the remaining participants, 35 (11%) 
reported yes, 285 (87%) reported no and 6 (2%) were unsure.   
 
 
 
 
 
 
†
11 HbA1c blood samples were outstanding and were excluded 
 
Figure 4.2: Self reported DM 
 
The findings in Figure 4.2 are elaborated on in Table 4.3 according to the HbA1c 
measurements and then stratified by gender.  The self reported rates of DM in the study 
population (35/326, 11%) were 9% in females and 14% in males.  
 
 
 
 
 
 
SELF REPORTED DIABETES 
n = 326
†
 
 
YES 
35/326, 11% 
NO 
285/336, 87% 
UNSURE 
6/326, 2% 
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Table 4.3: Reporting of DM by gender (n=326) 
   HbA1c
††
 Total Female Male   
   (%) n=326 (%) n=203  (%) n=123  (%) p-value 
Reported yes           0.659* 
(control) Normal < 5.7 8  (2) 3 0 (9) 5  (14)  
n = 35
†
 IGT 5.7 < 6.4 4  (1) 2  0(6) 2  0(6)  
 DM ≥ 6.4 23  (7) 13  (36) 10  (29)  
  Total    18  (51) 17  (49)  
Reported no           0.003* 
(undiagnosed) Normal < 5.7 221 (68) 130  (46) 91  (32)  
n = 285
†
 IGT 5.7 < 6.4 52 (16) 44  (15) 8  0(3)  
 DM ≥ 6.4 12  (4) 8  0(3) 4  0(1)  
  Total    182  (64) 103  (36)  
Reported          
don't know Normal < 5.7 6  (2) 3 (50) 3 (50)   
n = 6
†
 Total    3 (50) 3 (50)   
† † 
Classification of DM as per the ADA (1) 
†
 11 HbA1c blood samples were outstanding and were excluded 
* statistically significant 
 
 
4.2.2.1 Prevalence of DM 
The prevalence of DM among the study participants included those previously diagnosed 
and individuals identified with high HbA1c among those who reported not having DM 
(Table 4.3). The prevalence was 14% (47/326) with similar distributions amongst males 
and females (Figure 4.3).  
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Figure 4.3: Prevalence of DM by gender 
 
The statistically significant relationship between age and categories of DM (Kruskal-
Wallis, p<0.001) was further described by gender. Normal HbA1c levels had significantly 
lower median ages from (kwallis2): 
 IGT (Female: p<0.001, male: p=0.004) 
 DM  (Female: p<0.001, male: p<0.001) 
 
The prevalence estimates for DM in this study are presented in Table 4.4.  The 
prevalence estimates for DM remained significant when adjusted for gender (p<0.010), 
age (<0.001) and gender and age together (p<0.001). Table 4.4 describes the median ages 
per category of HbA1c classification, while Figure 4.4 graphically represents the 
prevalence of DM by age categories.  
 
 
66 
 
Table 4.4: Prevalence of DM by age and gender (n=326) 
  Normal IGT DM 
Females  Prevalence
+
 136 (67) 46 (23) 21 (10) 
(n=203) Age# 42 (30-53) 50 (43-59) 55 (43-64) 
Males  Prevalence
+
 99 (81) 10 (8) 14 (11) 
(n=123) Age# 35 (25-51) 55 (52-61) 57 (43-68) 
Total Prevalence
+
 235 (72) 56 (17) 35 (11) 
(n=326) Age# 39 (27-52) 52 (44-59) 57 (43-66) 
+ 
number and (percentage) 
#
 median and (IQR) 
 
 
 
Most participants in this study had normal glycaemic control (235/326, 72%). The 
prevalence of IGT among females was high (23%) compared to males (8%), with females 
presenting at a younger median age than males. The prevalence of DM was similar in 
males and females, with females presenting at a younger median age. Among females, 
both impaired glucose tolerance (IGT) and DM were present in participants as young as 
20-29 years [Figure 4.4(a)]. While males presented at an older age with DM, IGT was 
found at a younger age [Figure 4.4(b)].  
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a. Female 
 
 
b. Male 
 
 
 
 
Figure 4.4: Prevalence of DM by age and gender 
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4.2.2.2 Control of DM 
Glycaemic control among diabetics was classified using the ADA criteria for the 
diagnosis of DM (1) as a proxy for control (as described in Chapter 3: Table 3.3). Figure 
4.5 describes the glycaemic control among those who reported having DM (35/326, 
11%). Few recorded optimal glycaemic control (8/35, 23%). The majority were poorly 
controlled (23/35, 66%). Those diagnosed with DM have been shown to have received 
education on diet, exercise and diabetic care (chi square test, p<0.001). This has, 
however, not translated to improved health practices with few exercising (Kruskal-
Wallis, p=0.183) and poor intake of fresh food and vegetables (chi square test, p=0.447) 
among those with DM.  
 
 
Figure 4.5: Levels of glycaemic control among diagnosed diabetics 
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4.2.2.3 Prevalence of pre-diabetes 
Those participants who reported not having DM (285/326, 87%) (Table 4.3) comprised a 
high number that would be classified as „pre-diabetic‟. These individuals have IGT and 
are likely to develop DM as well as CVD (1). Fifty two (52/285, 18%) participants are at 
risk of developing DM, with females being predominantly at risk (44/182, 24%). Both 
females and males presented with IGT from as young as 20-29 years of age (Figure 4.4).   
 
4.2.2.4 Factors associated with DM 
Table 4.5 describes the bivariate and multivariate factors associated with DM. The 
bivariate analysis found that DM was associated with increasing age and WC. There was 
a significant difference in the median ages of those with DM (57 years [IQR 43-66]) and 
those without (43 years [IQR 28-55]) (Mann-Whitney, p<0.001). Similar differences 
were recognised in WC where those with disease had markedly larger WC (105 ± 13 cm) 
than those without disease (97 ± 17 cm) (Student‟s t-Test, p=0.003). Higher educational 
attainment was protective against disease (OR 0.38, 95% CI 0.17-0.88). Further 
categorization of work found that those retired were highly associated with having DM 
(OR 3.39, 95% CI 1.54-7.47). 
 
Increasing age remained significant, with those with a previous diagnosis of HPT also 
having higher odds of having DM (aOR 2.23, 95% CI 1.19-4.19). There was no evidence 
of multicollinearity in the multivariate model.  
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Table 4.5: Factors associated with DM on bivariate and multivariate regression 
(n=326) 
 Bivariate  Multivariate
 
(p<0.001) 
  
Odds ratio 
 
95% CI 
 
p-value 
 Adjusted 
Odds Ratio 
 
95% CI 
 
p-value 
Socio-demographic       
Gender 1.11 0.54 – 2.29   0.770*     
Age 1.05 1.02 – 1.07   <0.001*  1.03 1.01-1.06 0.012* 
Marital status 1.29 1.04 – 1.61 0.022*     
Education  0.38 0.17 – 0.88   0.024*     
Work 1.50 1.10 – 2.04 0.011*     
SES 0.62 0.34 – 1.14   0.123*     
Fruit & vegetable 
consumption 
1.28  0.64 – 2.57   0.477*     
Alcohol use 1.16 0.57 – 2.36   0.487*     
Tobacco use 0.87 0.32 – 2.36   0.777*     
Energy 
expenditure 
0.99 0.99 – 1.00   0.744*     
Family history  0.77 0.40 – 1.49   0.439*     
Clinical        
WC 1.03 1.01 – 1.05 <0.001*  1.02 1.00-1.04 0.044* 
Weight 1.02 1.00 – 1.03 0.048*     
BMI 1.01 0.99 – 1.04   0.283*     
Prev. diag. - HPT 3.32 1.84 – 5.99 <0.001*  2.23 1.19-4.19 0.013* 
SBP 1.01 1.00 – 1.02   0.048*     
DBP 1.00 0.98 – 1.02   0.911*     
* statistically significant 
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4.2.3 HYPERTENSION 
 
Figure 4.6 describes the self reported prevalence of HPT. From the 337 participants, 111 
(33%) reported yes, 220 (65%) reported no and 6 (2%) were unsure.   
 
 
 
 
 
 
 
Figure 4.6: Self reported HPT 
 
The findings in Figure 4.6 are elaborated on in Table 4.6 according to the combined SBP 
and DBP measurements. The self reported rates of HPT in the study population (111/337, 
33%) were 38% in females and 24% in males.  
 
 
 
 
 
 
 
 
SELF REPORTED HYPERTENSION 
n = 337 
 
YES 
111/337, 33% 
NO 
220/337, 65% 
UNSURE 
6/337, 2% 
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Table 4.6: Reporting of HPT by gender (n=337) 
   Total Female Male   
    n=337 (%) n=213  (%) n=124  (%) p-value 
Reported yes          0.411* 
(control) Normal 6   (2) 6  0(6) 0 0 (0)  
n = 111 Pre-HPT 37 (11) 28  (25) 9  0(8)  
 Stage 1  39 (12) 27  (24) 12  (11)  
 Stage 2 29   (9) 20  (18) 9  0(8)  
  Total 111 (34) 81  (73) 30  (27)  
Reported no          0.026* 
(undiagnosed) Normal 25   (7) 20  0(9) 5  0(2)  
n = 220 Pre-HPT 112 (33) 64  (29) 48  (22)  
 Stage 1  57 (17) 35  (16) 22  (10)  
 Stage 2 26   (8) 10    (5) 16 0 (7)  
  Total 220 (65) 129  (59) 91  (41)  
Reported        0.606* 
don't know Normal 1   (0) 1  (17) 0    (0)  
n = 6 Pre-HPT 2 (0.5) 1  (17) 1  (17)  
 Stage 1  2 (0.5) 1  (17) 1  (17)   
 Stage 2 1   (0) 0    (0) 1  (17)   
  Total 6   (1)  3  (50)  3  (50)  
* statistically significant 
 
 
4.2.3.1 Prevalence of HPT 
The calculated prevalence of HPT among the study participants included those previously 
diagnosed and newly identified individuals with elevated BP measurements among those 
who reported not having HPT and among those who were unsure about the diagnosis 
(Table 4.6). Figure 4.7 demonstrates the prevalence at 58% (197/337) with similar 
distribution in females (60%) and males (56%). 
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Figure 4.7: Prevalence of HPT 
 
Figure 4.8 classifies the prevalence of HPT by (a) DBP, (b) SBP and then a combination 
of the two (c). Systolic blood pressure and DBP were found to be correlated (r=0.769, 
p<0.001). There are no significant differences between males and females when 
comparing the means of SBP (p=0.070) or DBP (p=0.333). Only six percent of the 
female population recorded normal SBP, with 35% identified as prehypertensive. 
Combining the data yielded approximately 10% of participants with normal BP with the 
majority in both genders being prehypertensive [Figure 4.8(c)].  
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a. Diastolic blood pressure 
 
 
b. Systolic blood pressure 
 
 
c. Combined blood 
pressure measurements 
 
Figure 4.8: Prevalence of HPT by category and gender 
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The statistically significant relationship between age and classes of HPT (Kruskal-Wallis, 
p<0.001) was then further described by gender. Among the genders, the following 
relationships showed significant differences in median ages (kwallis2):  
 normotensive and Stage 1 (Female: p=0.002) 
 normotensive and Stage 2 (Female: p<0.001) 
 prehypertension and Stage 2 (Female: p<0.001, male: p=0.002) 
 
The prevalence of HPT is described Table 4.7. The prevalence estimates for HPT 
remained significant when adjusted for age (p=0.002), gender (p=0.014) and age and 
gender together (p=0.002). Table 4.7 describes the median ages in each category of HPT 
by gender while Figure 4.9 graphically represents the prevalence of disease by age 
categories.  
 
Table 4.7: Prevalence of HPT by age and gender (n=337) 
     Normal Prehypertension   Stage 1  Stage 2 
Females  Prevalence
+
 27 (12) 93 (44) 63 (30) 30 (14) 
(n=213) Age# 33 (26-47) 43 (30-57) 46 (35-55) 55 (47-64) 
Males  Prevalence
+
 5 (4) 58 (47) 35 (28) 26 (21) 
(n=124) Age# 46 (23-51) 33 (25-52) 36 (27-55) 53 (36-61) 
Total Prevalence
+
 32 (9) 151 (45) 98 (29) 56 (17) 
(n=337) Age# 33 (26-55) 40 (27-56) 45 (32-55) 55 (43-63) 
+ 
number and (percentage) 
#
 median and (IQR) 
 
The prevalence of prehypertension in both males and females are high, with males (33 
years [IQR 25-52]) presenting at a considerably younger median age than females (43 
years [IQR 30-57]). Males presented with disease at earlier median ages for all categories 
of disease.   
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Figure 4.9 represents the prevalence of HPT by age and gender. Most participants were 
classed as prehypertensive which presented as early as 18-19 years of age. Females 
presented at an earlier age with Stage 1 disease (20-29 years) but later with Stage 2 
disease [Figure 4.9(a)].  Among males, Stage 1 disease presented around the same age as 
in females, but Stage 2 diseases presented earlier than in females [Figure 4.9(b)].  
 
a. Female 
 
 
b. Male 
 
 
 
Figure 4.9: Prevalence of HPT by age and gender 
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4.2.3.2 Prehypertension  
There were a high number (112/220, 51%) of „prehypertensive‟ candidates among those 
participants who reported not having HPT (Table 4.6). Prehypertension is not a disease 
category but rather identifies a group at high risk of developing HPT. The combined data 
table [Figure 4.8(c)] identifies 150 participants (45%) at risk of developing HPT with 
males being predominantly at risk (58/124, 47%).  
 
4.2.3.3 HPT control 
Blood pressure control  among hypertensives was classified using the JNC7 criteria for 
the diagnosis of HPT (6) as a proxy for control (as described in Chapter 3: Table 3.4). 
Few participants reporting HPT recorded optimal hypertensive control (6/111, 5%). 
Figure 4.10 describes the majority as being poorly controlled (68/111, 61%). Those 
diagnosed with HPT have been shown to have received education on diet and exercise 
(chi square test, p<0.001). This has not, however, translated to improved health practices 
with few exercising (Kruskal-Wallis, p=0.168) and poor intake of fresh food and 
vegetables (chi square test, p=0.429).  
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Figure 4.10: Levels of control among diagnosed hypertensives 
 
4.2.3.4 Factors associated with HPT 
Table 4.8 describes the bivariate and multivariate factors associated with HPT. The 
bivariate analysis found that increasing age, WC, weight, BMI and HbA1c levels is 
associated with having HPT. There was a significant difference in the median ages of 
those with HPT (48 years [IQR 35-58]) and those without (40 years [IQR 27-54]) (Mann-
Whitney, p<0.001). Similar differences were recognised in WC where those with disease 
had markedly larger WC (101 ± 15 cm) than those without disease (96 ± 17 cm) 
(Student‟s t-Test, p=0.003). Correspondingly, higher BMI levels were associated with 
HPT (30 kg/m2 [IQR 26-35] vs. 27 kg/m2 [IQR 23-33]) (Mann-Whitney, p=0.003). 
HbA1c levels were also slightly higher in those with disease (5.5% [IQR 5.2-5.9]) than 
those without (5.4% [IQR 5.1-5.7) (Mann-Whitney, p=0.036). Being single, married or 
widowed, but not divorced was associated with developing disease. Higher educational 
attainment was protective against having HPT (OR 0.55, 95% CI 0.35-0.86).  
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Factors identified on multivariate analysis account for 4% of the variation in HPT. Age 
remained significant, with increasing weight (aOR 1.02, 95% CI 1.00-1.03) also being 
associated with disease. There was no evidence of multicollinearity in the multivariate 
model. 
 
Table 4.8: Factors associated with HPT on bivariate and multivariate regression 
(n=337) 
 
 Bivariate  Multivariate (p<0.001) 
  
Odds ratio 
 
95% CI 
 
p-value 
 Adjusted 
Odds Ratio 
 
95% CI 
 
p-value 
Socio-demographic       
Gender 1.25 0.80 – 1.95   0.326*     
Age 1.03 1.01 – 1.04   <0.001*  1.02 1.01 – 1.04 0.002* 
Marital status 1.40 1.13 – 1.73 0.002*     
Education  0.55 0.35 – 0.86 0.009*     
Work 1.02 0.85 – 1.24   0.816*     
SES 0.91 0.60 – 1.38   0.378*     
Fruit & vegetable 
consumption 
1.14 0.75 – 1.74   0.528*     
Alcohol use 1.22 0.78 – 1.90   0.374*     
Tobacco use 1.34 0.74 – 2.44   0.329*     
Energy 
expenditure 
1.00 0.99 – 1.00   0.319*     
Family history  1.06 0.70 – 1.61   0.776*     
Clinical        
WC 1.02 1.01 – 1.04 0.003*     
Weight 1.02 1.01 – 1.03 0.004*  1.02 1.00 – 1.03 0.015* 
BMI 1.05 1.01 – 1.08 0.004*     
Prev. diag. - DM 0.98 0.58 – 1.65 0.935*     
HbA1c 1.25 1.02 – 1.53   0.033*     
* statistically significant 
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4.2.4 OBESITY 
 
4.2.4.1 Prevalence of obesity 
Forty two males (34%) and 59 females (28%) are classified as overweight (BMI ≥ 25 
kg/m
2
 <30 kg/m
2
) in this study population (Figure 4.11). The obesity levels (BMI ≥ 30 
kg/m
2
) are marked (133/337, 39%). Particularly concerning is the level of obesity among 
females reaching 54% (114/213) described in Figure 4.12.   
 
Figure 4.11: Prevalence of obesity by gender (n=337) 
 
Figure 4.12 categorizes the obesity among 114 female participants and the 19 male 
participants with the most being Class I disease (57/133, 43%). The relationship between 
obesity and gender was statistically significant (chi-square test, p<0.001).  
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Figure 4.12: Categories of obesity by gender 
 
The association between classes of BMI and gender remained significant when adjusted 
for age (p=0.003). The statistically significant relationship between age and classes of 
BMI (Kruskal-Wallis, p<0.001) was then further described by gender. Among the 
genders, the following relationships showed significant differences in median ages 
(kwallis2):  
 Underweight and obese  (Male: p<0.001) 
 Normal and obese  (Male: p=0.003, female: p=0.003,) 
 Underweight and overweight (Male: p<0.001) 
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The prevalence of overweight and obesity in this study is described in Table 4.9. The 
prevalence of categories of BMI remained significant when adjusted for age (p<0.001), 
gender (p<0.001) and age and gender together (p<0.001). Table 4.9 explains the median 
age per category of BMI while Figure 4.13 graphically represents the BMI by age 
categories.  
 
Table 4.9: Prevalence of categories of BMI by age and gender (n=337) 
  Underweight   Normal   Overweight  Obese 
Females  Prevalence
+
 6 (3) 34 (16) 59 (28) 114 (54) 
(n=213) Age#  31 (25-41) 34 (24-55) 47 (31-60) 48 (38-57) 
Males  Prevalence
+
 23 (19) 40 (32) 42 (34) 19 (15) 
(n=124) Age#  25 (22-40) 32 (25-49) 49 (32-58) 52 (43-56) 
Total Prevalence
+
 29 (9) 74 (22) 101 (30) 133 (39) 
(n=337) Age#  26 (23-40) 33 (24-51) 48 (32-59) 48 (39-57) 
+ 
number and (percentage) 
#
 median and (IQR) 
 
Obesity was marked among females with 34% of males being classified as overweight. 
Figure 4.13 graphically represents the prevalence of obesity by gender and age group. 
The levels of obesity among females were pronounced with females being overweight 
and obese from as young as 20-29 years of age [Figure 4.13(a)]. Males presented at the 
same age as females but most were overweight rather than obese aged between 20-29 
years of age [Figure 4.13(b)].  
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a. Female 
 
 
b. Male 
 
 
 
 
Figure 4.13: Prevalence of obesity by age and gender 
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4.2.4.2 Factors associated with obesity 
Table 4.10 describes the bivariate and multivariate factors associated with obesity. The 
bivariate analysis found increasing age, WC, SBP and DBP to be associated with obesity. 
Obesity was significantly associated with the female gender (OR 6.36, 95% CI 3.63-
11.14). Higher educational attainment was protective against being obese (OR 0.30, 95% 
CI 0.19-0.49). Further categorisation of work found that being retired was protective 
against being obese. Being married, widowed or divorced is also associated with obesity. 
Obesity is also associated with a previous diagnosis of HPT.  
 
There was a significant difference in the median ages of those obese (48 years [IQR 39-
57]) than those who were not (38 years [IQR 26-56]) (Kruskal-Wallis, p<0.001). Similar 
differences were recognised in WC where obese individuals had markedly larger WC 
(111 ± 13 cm) than those without disease (90 ± 12 cm) (Student‟s t-Test, p<0.001). Obese 
individuals had higher SBP (148 ± 25 mmHg vs. 142 ± 22 mmHg) (Student‟s t-Test, 
p=0.036) and DBP (92 ± 15 mmHg vs. 88 ± 14 mmHg) (Student‟s t-Test, p=0.004).  
 
Factors identified on multivariate analysis accounted for 52% of the variation in obesity. 
Female gender remained markedly significant (aOR 7.58, 95% CI 3.46-16.61) together 
with WC (aOR 1.19, 95% CI 1.13-1.25) and education levels (aOR 0.42, 95% CI 0.21-
0.86). There was no evidence of multicollinearity in the multivariate model. 
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Table 4.10: Factors associated with obesity on bivariate and multivariate regression 
(n=337) 
 Bivariate  Multivariate (p<0.001) 
  
Odds ratio 
 
95% CI 
 
p-value 
 Adjusted 
Odds Ratio 
 
95% CI 
 
p-value 
Socio-demographic       
Gender 6.36 3.63 – 11.14 <0.001*  7.58 3.46 – 16.61 <0.001* 
Age 1.02 1.01 – 1.04   0.001*     
Marital status 1.33 1.08 – 1.63 0.007*     
Education  0.30 0.19 – 0.49 <0.001*  0.42 0.21 – 0.86  0.018* 
Work 0.80 0.65 – 0.99 0.037*  0.55 0.41 – 0.74 <0.001* 
SES 0.99 0.92 – 1.06 0.795*     
Fruit & vegetable 
consumption 
0.82 0.53 – 1.26  0.359*     
Alcohol use 0.71 0.45 – 1.12 0.139*     
Tobacco use 0.86 0.46 – 1.60 0.639*     
Energy 
expenditure 
1.00 0.99 – 1.00  0.206*     
Family history  1.48 0.96 – 2.27 0.071*     
Clinical        
WC 1.16 1.12 – 1.20   <0.001*  1.19 1.13 – 1.25 <0.001* 
Prev. diag. - HPT 1.77 1.14 – 2.76 0.011*     
SBP 1.01 1.00 – 1.02   0.039*     
DBP 1.02 1.01 – 1.04 0.006*     
Prev. diag. - DM 1.07 0.63 – 1.80  0.812*     
HbA1c 1.17 0.93 – 1.48   0.173*     
* statistically significant 
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4.3 ASSOCIATIONS BETWEEN RISK FACTORS 
 
Trends in communicable diseases can be determined by using coefficients of 
determination (r-squared); however NCD‟s generally have a multi-factorial aetiology 
which explains why many of the associations have a low r-squared value with a 
correspondingly high p-value. Often, outlying (or extreme values) of a variable affects 
the relationship between two variables resulting in biased regression coefficients and 
corresponding low r-squared values. Removing these outlying values can improve the 
model and increase the r-squared value.  
 
4.3.1 BMI vs. SBP 
 
 
Figure 4.14: Scatter plot of SBP vs. BMI 
 
 
r
2
=0.02, p=0.007 
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Systolic blood pressure and BMI are correlated (r=0.168, p=0.002). The relationship 
appears to be a linear and significant (p<0.001) (Figure 4.14). The r-squared value only 
explains about 2.19% of the variation in SBP by BMI (r
2
=0.0219). This is probably due 
to the multi-factorial aetiology of HPT. Therefore, a residual analysis was done to fully 
explore the association.  
 
Normality: When testing the studentized residuals of SBP, the mean value was close to 0 
(mean = 0.0004) and the median value was slightly smaller than the mean (median = -
0.18), suggesting a normal distribution.  Ninety percent of all studentized SBP values of 
lie between -1.36 to 1.84 (95% CI -1.08 – 0.11). This suggests that there was little 
difference between the observed and predicted values of SBP.  
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Figure 4.15: Normality plots of residuals of SBP  
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The histogram of the residuals of SBP in Figure 4.15(a) appears approximately normally 
distributed. Figure 4.15(b), the normal probability-probability (normal PP plot) plot 
plotting the cumulative distribution of the residuals against the cumulative distribution of 
the SBP, confirms this. On statistical testing for normality (Shapiro Wilk test, p<0.001) 
however, the p-value was less than 0.05, thus the null hypothesis that the data are 
normally distributed was rejected. This data suggests that while SBP and BMI were 
associated, the increase in SBP is not accompanied by a consistent proportional change in 
the BMI.  
Common variance and linearity: Plotting the studentized residuals against the SBP 
values should show a random pattern in the residuals (Figure 4.16). In this case, the 
evidence is against the null hypothesis that the variance is homogeneous (Breusch-Pagan 
test, p=0.008). This plot suggests that SBP has a heterogeneous distribution confirming 
the variability described under Normality.  
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Figure 4.16: Plot of studentized residuals vs. SBP 
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Outliers & Cook’s distance: Values identified as outliers by Cook‟s Distance (which 
combine the leverage and residual values) were deleted (indicated by arrows in Figure 
4.17); and the models run again.  
 
 
Figure 4.17: Plot of leverage values against squared residuals of SBP 
 
 
Relationship once the outliers were removed: The model did not improve with removal 
of the outliers (r
2
=0.01). This implies that the curve describing the initial relationship 
between SBP and BMI in Figure 4.14 holds true. These findings have two important 
clinical implications. Firstly, despite the multiple variables implicated in the aetiology of 
NCDs, increasing levels of SBP can be expected as the BMI increases. The amount of 
change in BMI was variable and the relationship between SBP and BMI persists at even 
extreme values. This persistence makes these study findings generalizable.      
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4.3.2 BMI vs. DBP 
 
 
Figure 4.18: Scatter plot of DBP vs. BMI 
 
Diastolic blood pressure and BMI are correlated (r=0.20, p<0.001). The relationship 
appears to be a linear and significant (p=0.001) (Figure 4.18).  The r-squared value 
explains about 3.10% of the variation in DBP by BMI (r
2
=0.0310).  This is probably due 
to the multi-factorial aetiology of HPT. Therefore, a residual analysis was done to fully 
explore the association.  
 
Normality: When testing the studentized residuals of DBP, the mean was close to 0 
(mean = -0.0001) and the median was slightly smaller than the mean (median = -0.52), 
suggesting a normal distribution. Ninety percent of all studentized DBP values of lie 
between -1.52 to 1.91 (95% CI -0.11 – 0.11). This suggests that there was little difference 
between the observed and predicted values of DBP.  
 
r
2
=0.03, p=0.001 
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(a) Histogram of the residuals (b) Probability-probability plot of residuals 
Figure 4.19: Normality plot of residuals of DBP 
The histogram of the residuals in Figure 4.19(a) appears approximately normally 
distributed. The normal PP plot in Figure 4.19(b) also suggests this. On statistical testing 
for normality (Shapiro Wilk test, p<0.001) however, the p-value was less than 0.05, thus 
the null hypothesis that the data are normally distributed was rejected. This data suggests 
that while DBP and BMI were associated, the increase in SBP is not accompanied by a 
consistent proportional change in the BMI. 
Common Variance & Linearity test: The variance of the residuals for DBP were 
homogenous (Breusch-Pagan test, p=0.360), though plotting the residuals against the 
DBP appears to be a random distribution (Figure 4.20). This plot suggests that DBP has a 
heterogeneous distribution confirming the variability described under Normality. 
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Figure 4.20: Plot of studentized residuals and DBP 
 
Outliers & Cook’s distance: Outliers identified by Cook‟s Distance were deleted; and 
the models run again.  
 
Relationship once the outliers were removed: The model did not improve with removal 
of the outliers (r
2
=0.03). The initial model of the relationship between DBP and BMI in 
Figure 4.18 remains valid. Despite the multiple variables implicated in the aetiology of 
NCD‟s, the evidence suggests that increasing levels of DBP can be expected as the BMI 
increases. Again, these findings have two important clinical implications. Firstly, despite 
the multiple variables implicated in the aetiology of NCDs, increasing levels of DBP can 
be expected as the BMI increases. The amount of change in BMI was variable and the 
relationship between BMI and DBP persists at even extreme values. This persistence 
makes these study findings generalizable.      
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4.3.3 BMI vs. HbA1c 
 
 
Figure 4.21: Scatter plot of HbA1c vs. BMI 
 
HbA1c levels and BMI are correlated (r=0.38, p<0.001). The relationship appears to be a 
linear and significant (p=0.030) (Figure 4.21). The r-squared value explains about 1.45% 
of the variation in HbA1c by BMI (r
2
=0.0420). This is probably due to the multi-factorial 
aetiology of DM. Therefore, a residual analysis was done to fully explore the association. 
 
Normality: The distribution of the HbA1c data was tested using the residual values and 
the studentized residual values. When testing the studentized residuals of HbA1c, the 
mean value was close to 0 (mean = 0.005) and the median value was slightly smaller than 
the mean (median = -0.24), suggesting a normal distribution.  Ninety percent of all 
studentized HbA1c values of lie between -0.85 and 2.15 (95% CI -1.09 – 0.12). This 
suggests that there was little difference between the observed and predicted values of 
HbA1c. 
r
2
=0.01, p=0.030 
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Histogram of the residuals Probability-probability plot of residuals 
Before removal of outliers 
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After removal of outliers 
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Figure 4.22: Normality plot of residuals of HbA1c before and after removal of 
outliers 
The residuals of HbA1c in Figure 4.22(a) and (b) have a non-normal distribution. This 
was statistical confirmed (Shapiro Wilk test, p<0.001) with a p-value less than 0.05 
rejecting the null hypothesis of normal distribution. This data suggests that while HbA1c 
and BMI were associated, the increase in HbA1c is not accompanied by a consistent 
proportional change in the BMI. 
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Common Variance & Linearity test: The variance of the residuals was homogenous 
(Breusch-Pagan test, p=0.848). This suggests that HbA1c has a heterogeneous distribution 
confirming the variability described under Normality. 
 
Outliers & Cook’s distance: Outliers identified by Cook‟s Distance (which combines 
leverage and residual values) were deleted; and the models run again.  
 
Relationship once the outliers were removed: The model improved with removal of the 
outliers. The outliers represent aberrations that do not reflect the characteristics of the 
population being explored. Twelve percent of the variation in HbA1c can now be 
attributed to BMI levels (r
2
=0.12). The improvement in the model is graphically 
represented in Figure 4.22(c) and (d) though statistical testing still did not show normality 
in the distribution (Shapiro Wilk test, p<0.001).  This evidence shows that increasing 
levels of BMI was significantly associated with increases in HbA1c levels, though the 
amount of change could not be reliably predicted. 
 
The reason why outlying variables impact on the association between DM and BMI and 
not with the association between HPT and BMI (discussed in Section 4.4.1: BMI vs. SBP 
and Section 4.4.2: BMI vs. DBP) can only be postulated. Perhaps, it has to do with the 
difference in testing between DM and HPT, or that DM may present with intractable 
disease at an earlier age in this population.  
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The differences between the outlying values and the rest of the study population were 
explored further. The participants identified as outliers were older (55 vs. 43 years) 
(Mann-Whitney, p=0.001) and 57% were married (chi square test, p<0.001) with 78% 
have lower education levels (chi square test, p=0.003). Clinically, the outliers had 
significant histories of DM (chi square test, p<0.001) and HPT (chi square test, p<0.001) 
and had larger WC (104 ± 12cm vs. 98 ± 16 cm) (Student‟s t-test, p=0.043), BMI values 
(31 kg/m
2
 [IQR 27-36] vs. 28 kg/m
2
 [IQR 23-33]) (Mann-Whitney, p=0.026) and HbA1c 
(9.3% [IQR 8.4-10.4] vs. 5.4% [IQR 5.1-5.7]) (Mann-Whitney, p<0.001) levels than the 
rest of the study population. Apart from the impact of increased age and lower education 
levels on poor glycaemic control, it is possible that the significant history of HPT may 
have played a role in the extreme values demonstrated.  The significant history of DM 
among the outliers alludes to the poor control describes in Section 4.3.2.2: Control of 
DM.  
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4.3.4 HbA1c vs. SBP 
 
 
 
Figure 4.23: Scatter plot of HbA1c vs. SBP 
 
Systolic blood pressure and HbA1c are correlated (r=0.15, p=0.006). The relationship 
appears to be a linear and significant (p=0.033) (Figure 4.23). The r-squared value 
explains about 1.40% of the variation in HbA1c by SBP (r
2
=0.0140). This is probably due 
to the multi-factorial aetiology of DM. Therefore, a residual analysis was done to fully 
explore the association. 
 
Normality: When testing the studentized residuals of HbA1c, the mean was close to 0 
(mean = 0.006) and the median was slightly smaller than the mean (median = -0.24), 
suggesting a normal distribution. Ninety percent of all studentized HbA1c values of lie 
between -0.82 and 2.10 (95% CI -0.11 – 0.12). This suggests that there was little 
difference between the observed and predicted values of HbA1c. 
r
2
=0.01, p=0.033 
98 
 
Histogram of the residuals Probability-probability plot of residuals 
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After removal of outliers 
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Figure 4.24: Normality plot of residuals of HbA1c before and after removal of 
outliers 
 
The residuals of HbA1c in Figure 4.24(a) and (b) have a non-normal distribution. This 
was statistical confirmed (Shapiro Wilk test, p<0.001) with a p-value less than 0.05 
rejecting the null hypothesis of normal distribution.  
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This data suggests that while HbA1c and SBP were associated, the increase in HbA1c is 
not accompanied by a consistent proportional change in the SBP. This suggests that 
HbA1c has a heterogeneous distribution confirming the variability described under 
Normality. 
 
Common Variance & Linearity test: In this case, the evidence is against the null 
hypothesis that the variance is homogeneous (Breusch-Pagan test, p<0.001). 
 
Outliers & Cook’s distance: Outliers identified by Cook‟s Distance (which combines 
leverage and residual values) were deleted; and the models run again.  
 
Relationship once the outliers were removed: The model did not improve with removal 
of the outliers (r
2
=0.01, p=0.09). Despite the model improving graphically [Figure 
4.24(c) and (d)], the distribution of the data remained non-normal (Shapiro Wilk test, 
p<0.001).  In this study population, no significant relationship could be found between 
HbA1c levels and SBP.  
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4.3.5 HbA1c vs. DBP 
 
 
Figure 4.25: Scatter plot of HbA1c vs. DBP 
 
Diastolic blood pressure and HbA1c levels were not correlated (r=0.08, p=0.136) despite 
there being an appearance of a linear relationship (Figure 4.25).  The p-value for the 
overall regression model was not significant (p=0.456) implying no relationship between 
DBP and HbA1c.  
 
 
 
 
 
 
 
r
2
=0.00, p=0.456 
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4.4 THE METABOLIC SYNDROME 
 
In this section, factors related to the development of the MS are discussed. The blood 
samples collected for the lipid profiles were incorrectly stored making analysis of these 
samples impossible. Financial constraints did not allow for recollection of these samples. 
Additionally, HbA1c results (based on the ADA criteria for the diagnosis of DM) were 
used as a surrogate for the fasting plasma glucose samples. This was done considering 
that HbA1c blood sample collection represented a less labour intensive method given the 
financial and resource constraints of this project. The findings relating to the MS 
presented in this analysis is thus limited as it is based only on the waist circumference, 
hypertension and glucose criteria (using HbA1c as a surrogate) of the IDF definition of 
the MS (defined in: Glossary of terms). 
 
4.4.1 Prevalence of the MS 
 
Participants were assessed for the MS by gender. One hundred and ninety five females 
(92%) met the criteria of WC ≥ 80cm for the MS as stipulated by the IDF (chi square test, 
p<0.001). Only 64 males (52%) had WC ≥ 94cm. Raised HbA1c levels (HbA1c ≥ 5.6%) 
was found in 117 participants (89 female, 28 male). Seventy nine females and 25 males 
were diagnosed with the MS (chi square test, p<0.001). The prevalence of the MS in the 
study population was 31% (104/337). Fifty one females (24%) and 24 males (19%) met 
all three criteria for the diagnosis of hypertension (chi square test, p=0.329) for the 
diagnosis of the MS. Similarly, 18 females (8%) and 12 males (10%) fulfilled both 
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criteria for DM (chi square test, p=0.703) (data not shown). Table 4.11 demonstrates the 
prevalence of the MS and the associated risk factors. 
 
Table 4.11: Prevalence of the MS and associated risk factors (n=337) 
 
Variable Total Female Male  
 n=337 (%) n=213 (%) n=124 (%) p-value 
Diagnosed with MS 104 (31) 79 (23) 25 0(7)  0.001* 
        
Risk factors for MS        
WC‡ 259 (77) 195 (58) 62 (19) <0.001* 
History of hypertension 111 (33) 81 (24) 30 0(9) 0.032* 
SBP  130mmHg 243 (72) 145  (43) 98 (29) 0.030* 
DBP  85 mmHg 213 (63) 129 (38) 84 (25) 0.188* 
History of DM 37 (11) 20 0(6) 17 0(5) 0.439* 
HbA1c  5.6% 117 (35) 89 (26) 28 0(8) <0.001* 
* statistically significant 
‡ meeting the IDF criteria for WC ( 94cm-males,  80cm-females) (9) 
 
 
 
4.4.2 Factors associated with the MS  
 
The analysis in Table 4.12 reflects the significant association of female gender, older age 
with the MS on both bivariate and multivariate analysis. Lower levels of education were 
again associated with disease. The MS had no associations with SES or with levels of 
consumption of alcohol or use of cigarettes.  
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Table 4.12: Factors associated with the MS on bivariate and multivariate analysis 
(n=337)  
 Bivariate  Multivariate (p<0.001) 
  
Odds ratio 
 
95% CI 
 
p-value 
 Adjusted 
Odds Ratio 
 
95% CI 
 
p-value 
Socio-demographic       
Gender 2.33 1.38 – 3.94 0.002*  2.32 1.33 – 4.06 0.003* 
Age 1.06 1.04 – 1.08 <0.001*  1.06 1.04 – 1.08 <0.001* 
Marital status 1.36 1.10 – 1.67 0.004*     
Education  0.27 0.16 – 0.46 <0.001*     
Work 1.48 1.20 – 1.82 <0.001*     
SES 1.23 0.78 – 1.96 0.502*     
Fruit & vegetable 
consumption 
1.04 0.66 – 1.64 0.849*     
Alcohol use 1.22 0.76 – 1.96 0.406*     
Tobacco use 0.89 0.46 – 1.72 0.733*     
Energy 
expenditure 
1.30 0.48 – 3.50 0.600*     
Family history  1.18 0.76 – 1.83 0.468*     
*statistically significant 
 
4.5 SUMMARY OF THE CHAPTER 
 
This chapter outlined the key results of the study. The study population was black with 
middle to higher SES and education levels below Grade 12 mostly. The prevalence of 
DM in this study population was 14%, with many undiagnosed individuals and those with 
disease having poor control. More than half the study population had HPT (58%) and 
most were sub-optimally or poorly controlled. This was a markedly obese population 
(39%) with 54% of women having a BMI categorised as obese (BMI ≥ 30 kg/m2). There 
is a high prevalence of the MS (31%) with the syndrome affecting mostly females 
(79/213, 37%).  
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CHAPTER 5 
DISCUSSION 
 
This chapter describes the findings of the study in the context of the available literature. 
The clinical information will be discussed first followed by the socio-demographic data.  
 
5.1 INTRODUCTION 
 
The study aims to determine the prevalence of cardio-metabolic diseases and the 
associated risk factors in the community of Chiawelo, Johannesburg Health District, 
Gauteng Province.  This data will hopefully contribute to reducing the burden of disease 
through early screening and identification of cases, improving long term management and 
minimising the development of complications by targeting the at-risk populations.  
 
5.2 DIABETES MELLITUS 
 
5.2.1 Prevalence of DM  
 
The self-reported prevalence of DM is 11% (35/326). This differs from the calculated 
prevalence of DM of the study population classified according to the HbA1c results in the 
current ADA guidelines (1). According to this classification, the prevalence is 14% 
(47/326) with similar distributions amongst males and females. When considering DM 
prevalence, data from rural areas in South Africa suggest rates of 8.8% in females and 
8.5% in males (28). In Gauteng, the prevalence has steadily increased from 28% in 2005 
105 
 
to a staggering 73% in 2007 according to the DHIS data (127), though the reliability of 
this data may be brought into question. In 2006/07, the incidence of DM is thought to 
have stabilised in Gauteng Province, with approximately 112 new cases per 100 000 
people 45 years and older, diagnosed annually (56).  
 
While SEMDSA does not advocate the use of the HbA1c for diagnosing DM (123;124), 
the prevalence of 14% calculated in this study based on HbA1c data, in the background of 
previously reported prevalence of 5.5% among South Africa adults aged 30 years and 
over in 2001 (128) and 5-8% in the black population in 2009 (129), cannot be ignored.  
 
From those participants not reporting DM, there is a high number that are classified as 
„pre-diabetic‟ (52/285, 18%) with females predominating (44/182, 24%). These 
individuals have IGT, are likely to develop DM, and render themselves susceptible to the 
complications that are associated with poor glycaemic control. Data from the rural 
Ubombo district in Kwa-Zulu Natal confirms the epidemic proportions of glucose 
intolerance in that community, which far exceeds other rural communities in Africa 
(130). The Framingham Heart Study also highlights pre-diabetes as a key risk factors for 
the development of DM (52). These pre-diabetic conditions have a 25-50% lifetime risk 
of developing DM and this group should be specifically targeted for primary preventative 
strategies (131). Both the Finnish Diabetes Prevention Study and the Chinese Da Qing 
Study have conclusively shown that that the progression to DM from a pre-diabetic state 
can be prevented through dietary modification to promote weight loss and increasing 
levels of physical activity (73;132).  
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The Framingham Offspring Study and NHANES 2001-2004 found HbA1c to be 
positively associated with age in non-diabetic subjects (133). Globally there has been a 
foreboding decline in the age of diagnosis of DM with between 8-45% of all new cases 
diagnosed in children and teenagers (134). While the 2004 National programme for 
control and management of Diabetes Type 2 at primary level identified those older than 
60 years at risk of DM (96), findings from this study suggest earlier age of onset (Chapter 
4: Table 4.7) for both IGT and DM.  
 
5.2.2 Identifying undiagnosed cases 
 
The testing of HbA1c levels in the study identifies 12 individuals with undiagnosed DM 
(12/326, 4%) from those who did not report having DM. These are similarly distributed 
between the males (3%) and females (4%). However, many studies have reported that 
DM is a stronger risk factor for CVD in females than in males, with a 50% higher relative 
risk in females than in males (125). Bearing this in mind, current data suggests that more 
than half of women and three quarters of men in requiring intervention for HPT and DM 
in South Africa are unaware that they are suffering from these conditions (135), 
emphasizing the need for early diagnosis.  
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5.2.3 Management and control of DM 
 
Deranged glycaemic control together with all other cardio-metabolic disease parameters 
support the fact that comprehensive diabetic care appears to be lacking in the three major 
academic hospitals in Johannesburg (129). Few participants in this study have optimal 
glycaemic control (8/35, 23%) from those who report having the disease (35/326). The 
majority are poorly controlled (23/35, 66%). Levitt et al showed that black South African 
patients had a poor ability to manage their disease (136). Self management of diabetes is 
knowledge dependant and this reflects a poor understanding of the disease by the black 
South African population (50) which is in keeping with the educational level of this 
population and its association with age.  
 
Rural studies conducted in Limpopo Province found that black patients with DM had 
poor levels of glycaemic control but also presented with related conditions as 
dyslipidaemia,  obesity and elevated BP levels (137). Many studies have shown that DM 
has sub-optimal control in South Africa, with education having a positive, but not very 
impressive, impact on glycaemic levels (138). This is important because health literacy 
must be considered in formulating diabetes education. Perhaps the answer lies in 
engaging the patient more in the management of their condition. Evidence from 
controlled clinical trials point to the fact that programmes focussing on self-management 
skills have proven to be more effective than information only patient education in 
improving clinical outcomes (139).  
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5.2.4 Factors associated with developing DM  
 
Increasing age and a previous diagnosis of HPT are associated with developing DM on 
multivariate analysis. Lower education levels are associated with disease on bivariate 
analysis and this cross-cuts the discussion on the interplay between age and education 
level. Increasing weight and a history of HPT (all factors inextricably linked) are 
associated with DM.  
 
5.3 HYPERTENSION 
 
5.3.1 Prevalence of HPT  
 
The self-reported prevalence of HPT is 33% (111/337). This differs from the calculated 
prevalence of HPT of the study population classified according to the current guidelines 
(6). According to this classification, the prevalence is 58% (197/337) with similar 
distribution in females (60%) and males (56%).  This is in keeping with the prevalence 
rates of HPT identified in the Heart of Soweto Study at 33% for either SBP or DBP 
elevation (34). Many South African studies from as early as 1998 have confirmed the 
high levels of BP and HPT in black people (35;45;140) but have rates significantly higher 
in obese, black women (104) while this research report shows comparable rates in males 
and females. The prevalence of HPT in this study far exceeds the self-reported rates in 
Gauteng adults in 2006/07 (9% for males, 21% for females) (56). Rural South African 
data seems more feasible with a HPT prevalence of 26% in females and 22% in males 
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(28). Data from the 1996 Mamre Study looking at a coloured community in Cape Town 
showed HPT prevalence rates of 22% in men and 16% in females (141).  
 
From those participants not reporting having HPT, there is a high number that are 
classified as „prehypertensive‟ (112/220, 51%) with males predominating (58/124, 47%). 
These individuals form a group at high risk of developing HPT. The identification of this 
group is vitally important as it is known that HPT occurs at an earlier age, is more severe 
and is more likely to result in early end-organ damage in the black population (34). Males 
present at an earlier age with prehypertension and HPT in this study. This is supported by 
South African data showing mean SBP increases with age and this was higher in men 
than in women at all ages (57).  
 
There does appear to a clearly defined age at which screening for HPT should occur in 
South Africa, probably because BP measurements are routinely conducted at most PHC 
visits (opportunistic screening). The 2006 South African Hypertension Guideline 
consider DM (in females > 65 years and males > 55 years) and family history of early 
onset of CVD (in females aged < 65 years and males aged < 55 years) as major risk 
factors for the development of HPT (97). The ages documented in this study for 
prehypertension and HPT were low, particularly among males. The median age of 
prehypertension was 43 years (IQR 30-57) among females and 33 years (IQR 25-52) 
among males with increasing ages in both genders as they reached more severe levels of 
disease.  
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5.3.2 Identifying undiagnosed cases 
 
Measuring BP in this study identifies 83 individuals with undiagnosed HPT (83/337, 
25%) from those not reporting HPT. These undiagnosed cases represent 42% of males 
and 35% of females. This is a major proportion of the study population reflecting the high 
burden of disease even for this sample.  
 
5.3.3 Management and control of HPT 
 
Few recorded optimal hypertensive control (6/111, 5%) from those reporting having the 
disease (111/337).  The majority are poorly controlled (68/111, 61%). These findings are 
significantly different from data at three primary care sites servicing three townships in 
Cape Town that showed optimal control in 33% of men and 44% of women (58). It is 
vital that the poor control in this study be addressed as higher levels of SBP and DBP 
have been documented in black women (29) and the general black population has been 
shown to have twice the CVA rates than their white counterparts (35). Many large 
epidemiological studies have shown that a simple 2 mm Hg reduction in mean BP will 
decrease the risk of CVD by 10% (23).  
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Barriers to optimum HPT care exist at the level of  the patient, provider and organisation 
and include lack of awareness of the dangers of untreated HPT or the benefits of control, 
poor patient-provider relationships, unemployment rates, cost of care and medications 
and side effects (58). Improved HPT control can be achieved with active participation of 
the patient through greater awareness and knowledge and explanation of their actual BP 
measurements (58).  
 
5.3.4 Factors associated with developing HPT  
 
Increasing age and weight are associated with developing HPT. Family history did not 
impact on disease prevalence in this population. Again, the importance of education is 
highlighted with lower levels of education being associated with developing HPT.  The 
HiHi Study found that significant predictor of lower levels of SBP, DBP or BP control 
included: fewer medications prescribed, better compliance to HPT recommendations, 
younger age, female respondents, higher levels of education and attending private health 
care (58). In addition to these, the 1998 SADHS also quoted family history and obesity as 
significantly associated with the risk of HPT (104).  
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5.4 OBESITY 
 
5.4.1 Prevalence of obesity 
 
The change in diet to more saturated fats and sugars is largely responsible for high rates 
of obesity characterising the emergence of NCDs in South Africa, particularly in urban 
black women (29;56). The obesity levels (BMI ≥ 30 kg/m2) are marked (133/337, 39%) 
in this research. Particularly concerning is the level of obesity among females reaching 
54% (114/213). The Heart of Soweto Study identified obesity as the most prevalent CVD 
risk factor (43%) with 55% of women classified as obese (34). Data from rural South 
Africa identified 52% of females as overweight or obese (28). The 2003 SADHS 
demonstrated that approximately 10% of adult men and 30% of adult women in Gauteng 
were obese, while 20% of adult men and 28% of adult women are overweight (142). This 
study found much higher rates of being overweight in males (42/124, 34%) but similar 
rates in females (59/231, 28%).   
 
The HiHi study showed that 85% of participants were overweight or obese despite these 
participants perceiving themselves to be of normal or under-weight (58). These 
perceptions were highly associated with education levels among black South Africans 
with the least educated black males and females having the greatest discrepancies 
between actual and perceived BMI (58;61). Being overweight and/or obese poses a 
significant risk to health, especially among females, with 87% of patients with DM, 68% 
of hypertensives and 38% of those with IHD having a BMI greater than 21 kg/m
2 
in the 
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1998 SADHS (143). Despite the perceptions of weight and the possible sensitivity 
surrounding the issue of being overweight or obese, the epidemic has to be addressed.  
 
5.4.2 Factors associated with developing obesity  
 
Obesity was associated with WC on both bivariate and multivariate assessment. In the 
Gauteng study, WC is also the parameter that differentiated between the presence and 
absence of the MS in patients with both HPT and DM (59). Lower levels of education are 
again associated with disease. Apart from WC, gender was also associated with the MS 
on multivariate analysis. High levels of obesity among females is a recurring theme in the 
literature (29;34;56).  
 
5.5 ASSESSMENT OF CARDIOVASCULAR RISK FACTORS 
 
Unlike communicable diseases, NCDs generally have a multi-factorial aetiology which 
explains why many of the associations discussed have a low r-squared value with a 
correspondingly high p-value.  The residual analyses are being done to better interpret the 
relationship between these risk factors.  
 
In this study population, increasing values of SBP and DBP can be expected as the BMI 
increases. However, similar increases in BMI are not associated with increases in HbA1c 
in this population. This negative finding is to the contrary of existing data that supports 
an inter-relationship between all risk factors. Increased body weight is a highly prevalent 
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and highly implicated component of the MS, but it also has strong associations with DM, 
HPT, dyslipidaemia and atherosclerosis (80). Data from the UK show that mortality from 
CVD increases incrementally as the presence of the MS features increase (144).  
 
This study also demonstrated increasing levels of BMI to be significantly associated with 
increases in HbA1c levels. Many studies have identified obesity as an important 
independent modifiable predictor of DM (8;51), with almost 80% of people overweight at 
the time of diagnosis of DM (8). The United Kingdom Prospective Diabetes Study 
(UKPDS) observed that the mean BMI at the time of DM diagnosis was 28 – 29 kg/m2  
(145). Most cases, however, will present at a BMI or between 25 – 30 kg/m2  (146). There 
are probably differences in disease development based on ethnicity with Asians 
developing disease at lower BMI values than the white population (51). Again, data on 
the black population is lacking.  
 
Smoking accounted for between 41 632 – 46 656 deaths in South Africa in 2000, with 
three times more deaths in males than females, mostly attributable to CVD (147). The 
high mortality in males is likely due to the fact that male smoke more tobacco than 
females. The prevalence of tobacco use was higher in males (57%) than in females (36%) 
in studies conducted in the Limpopo Province (28). Perhaps the lower levels of tobacco 
use in this study (52/337, 15%) could be the result of the stringent anti-tobacco laws 
currently in place.  
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5.6 THE METABOLIC SYNDROME  
 
The MS was defined using the IDF criteria for WC, HPT and DM but using HbA1c levels 
as a surrogate for fasting plasma glucose levels (Section 3.6.1.2 Clinical variables: 
Metabolic syndrome). Lipid profile results were unavailable.  
 
5.6.1 Prevalence of the MS 
 
The prevalence of the MS in the study population is 31% (104/337) with 37% female 
(79/213) and 20% male (25/124). The rate of disease in the study population is 
significantly higher than the 25% prevalence reported among black South African women 
in 2009 also using the IDF criteria (148). The prevalence of MS was 60% in a group of 
40 patients with established CAD and no previous history of DM in Johannesburg (59)  
Most participants (257/337, 76%) met the IDF criteria for WC for the diagnosis of the 
MS with the majority being female (92%) (1;9). These rates are particularly higher than 
South African studies conducted among students that found only 24% of females and 
14% of males exhibited WCs above the acceptable range (149). The POWIRS (Profiles 
of Obese Women with the Insulin Resistance Syndrome) study found that 48% of black 
women exceed the IDF criteria for WC (29). Perhaps this reflects the more sedentary 
lifestyle of the study population compared to that of a student population.  
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5.6.2 Factors associated with the MS 
 
Female gender and increasing age are associated with having the MS on multivariate 
analysis. Both this research report and preceding studies have associated female gender 
with disease (29;149). In Johannesburg, increased WC with HPT and elevated glucose 
levels were found to be the most recurring combination of risk factors implicated in the 
development of the MS in a study of 40 black subjects with established CAD but these 
individuals did not report a previous diagnosis of DM (59).  
 
Significant associations are found with age and the development of the MS on bivariate 
analysis. This is important as data from the Coronary Artery Development in Young 
Adults (CARDIA) study found the MS to be associated with increasing age and appeared 
to be more prevalent in the black population (150). There are no associations between the 
MS and physical activity in this study even though higher levels of physical activity 
confer protection against the syndrome (150). 
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5.7 THE ROLE OF DIET AND PHYSICAL ACTIVITY  
 
Intensive interventions combining drug therapy and behaviour modification have shown 
sustained benefits in respect vascular complications and mortality rates in high risk DM 
patients (151). Behaviour modification encourages increased levels of physical activity 
coupled with appropriate dietary choices. Participants identified as hypertensive and 
diabetic both reported receiving education on diet and exercise at PHC facilities. This did 
not translate into improved consumption of fruit and vegetables or increased levels of 
physical activity. This could be due to the patients not heeding the advice given or 
perhaps, the distinction between health education and health promotion on the part of the 
health services needs to be clarified.  
 
The Finnish Diabetes Prevention Study showed that moderate-vigorous activity and low 
intensity activity both resulted in reduced incidence of DM in a dose-dependent manner 
and independent of changes in diet and BMI (51). Data from the US based Diabetes 
Prevention Programme also showed that moderate activity for 30 minutes/day coupled 
with a 10% reduction in body weight translated to a 50% reduction in diabetes in high-
risk IGT patients (131).  Despite the convincing evidence to the contrary, this study did 
not demonstrate any impact of reported levels of physical activity on disease 
development or control. This may be due to inaccurate reporting of physical activity, as 
the questionnaire did call for recall of activities over a period of time. Few reported high 
activity levels, and it is likely that the majority were not engaging in physical activity.  
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Four participants (4/330, 1%) report never eating fresh fruit and vegetables at all while 
61% report consumption five or more times per week (200/330). This information about 
diet is not associated with disease development or control. Data regarding intake of 
proteins (e.g. red meat), starch saturated fats is not available and might be the reason for 
the fresh fruit and vegetable consumption not being significant. This is an important 
concept as few diabetic patients (58%) identified maize as a food with high carbohydrate 
content despite it being a staple food in South Africa (50).  It is suggested that this lack of 
knowledge compounded by poor dietary choices could predict for co-morbidities later 
(50).  
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5.8 SOCIO-DEMOGRAPHIC FACTORS 
 
5.8.1 Gender and race 
 
The study comprises 337 participants; 336 of whom are black. Identifying the study 
population as black is an important component of this study. Previous studies report that 
apart from the rural-urban gradient, there exists a gradient across population groups with 
DM being highly prevalent in the Indian community, followed by the coloured and then 
black populations (53) but the prevalence is growing in the black communities with 
ageing and lifestyle changes (50). Epidemiological information among the black 
population in Southern Africa reflects not just an increase in DM rates, but in other 
chronic diseases as well that are known to be more prevalent in the urban black 
populations (152). It is the measure of this change in South Africa that needs to be 
ascertained. Another important consideration in terms of race is that 90% of the black 
South African diabetic population access public health facilities with only 8% able to 
access private health care (50). Thus, this data should be able to provide an accurate 
estimate of the care received by those attending PHC facilities.  
 
The majority of participants are female (213/337, 63%). The predominance of the female 
participants in the study population (63%) is in keeping with previous South African 
studies assessing chronic diseases, particularly DM, in the public clinics and the 
community (50;153). The apportionment of the study by gender is important because 
women are known to have better health seeking behaviour and the study sample is 
representative of what would be expected in a PHC facility.  
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5.8.2 Age and educational level  
 
There is a wide variation in the ages of those interviewed with a median age of 44 years 
(IQR 30-56) and a range of 18 – 93 years. The wide age band is an important 
consideration in self monitoring of chronic diseases. Research has shown that there is a 
3% reduction in the knowledge score of diabetics for every ten year increase in age (50) 
so this is likely to explain poor levels of control in the older participants. Moodley and 
Rambiritch showed that the highest levels of diabetes knowledge was in the 40-59 year 
age group, which is the majority of this study population, and the lowest among the 60-79 
year old patients in a Kwa-Zulu Natal clinic survey assessing DM knowledge among 
patients (50).  
 
Many participants have attended high school (124/334, 37%) with 26% (88/334) having a 
matriculation certificate. A poor understanding of DM has been suggested as the reason 
for the poor glycaemic control in the black population (136). This may be  attributable to 
the inequalities of education under apartheid that saw the white population having better 
facilities in both the private and public sector and a system of education that permeated 
through the clinics, schools and media (50). Most of this study population is older and 
have been schooled prior to the political changes of 1994, and thus subject to poor 
standards of education.   
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While only a small number received no formal education (9/334, 3%), it is important to 
consider the impact of this on disease development. Schutte and Olckers show in a study 
comparing South African women that unschooled black women have a 4.8 times higher 
risk of having the MS than schooled women (29). If the well documented inverse 
relationship between education levels and the development of CVD events hold true 
(154), it is not unanticipated to have high levels of disease in this study population.  
 
5.8.3 Employment status 
 
The unemployment rate in the study population is high (168/337, 50%) with 56% of 
females unemployed. While unemployment does not automatically equate to a sedentary 
lifestyle, it is likely to be so and may afford an explanation as to the high levels of obesity 
particularly among females. Twenty percent of females (42/213) and 37% of males 
(46/124) are employed.  
 
5.8.4 Social grants remittances  
 
Females are mostly dependant on the child support grants (47/88, 53%) and the median 
age of the women accessing these grants is 32 years (IQR 29-40). The introduction of the 
child support grant by the South African government in 1998 was intended as a poverty-
alleviation measure though the poorest households are unlikely to access them (155). The 
SES of this community is middle to high income, and many have recourse to these grants 
(155). 
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5.9 PUBLIC HEALTH IMPLICATIONS OF THIS STUDY 
 
The public health implications of this study extend beyond the clinical diagnosis and 
management of this cluster of diseases. This section is presented considering the „Grand 
Challenges in Chronic Non-communicable Diseases‟ that were formulated to reduce the 
burden of disease through finance, debate and evidence based guiding policies (156;157).  
 
5.9.1 Raising public awareness 
 
Public education and awareness has been shown to impact on disease control and 
development. Health education needs to be encouraged in schools and is essential in all 
health care facilities. The message that is conveyed needs to be culturally sensitive and in 
an appropriate language and medium of communication to reach the entire community 
and not just the clinics and schools. For a public health intervention to be successful, the 
programme must simultaneously account for all CVD risk factors in an integrated, 
intervention involving co-ordination from policy makers, mass media messaging and 
commitment from the food industry to reduce the salt content of staple foods and provide 
correct labelling of food through policy and legislative development (57).  
 
Interventions aimed at chronic disease prevention can take years to yield benefits. 
Changing behaviours is difficult and requires time, effort and considerable motivation. 
Perhaps these would be more readily achieved if the process was initiated through 
clinically based primary care treatments targeting those at risk for chronic diseases, 
particularly CVD and DM (19).  
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5.9.2 Modifying risk factors 
 
Comprehensive community-based lifestyle interventions, even in the developing 
countries, can alter the environment of the entire community to support healthier lifestyle 
choices which would translate to limiting health risk behaviours and ultimately, reducing 
the morbidity and mortality attributable to NCDs (20).  
Enabling environments for such changes must be encouraged in schools, clinics and the 
community such that the entire community is reached, irrespective of whether they have a 
disease. Strategies such as increased availability of health foods, especially at schools; 
promoting physical activity and addressing misperceptions about weight have a vital role 
to play in reducing burden of disease.  
 
5.9.3 Generation of accurate information 
 
National, provincial and local government, together with policy-makers has a pivotal role 
in the generation of information to help guide the development of preventative and 
treatment programmes, especially for those living in poverty. Early identification of those 
at risk and those with the disease through the generation of current, accurate and reliable 
data will serve as the first step in the process of effective management. Besides informing 
policies, surveillance data plays a vital role in evaluating health policies and preventative 
interventions. The information collected must be analysed and fed back into the health 
system to advise policy and allow for priority setting tailored to the needs of the 
community. It is vital that chronic disease surveillance be more comprehensively 
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integrated into the district and national health information systems with regular 
monitoring of the data guiding policy. To achieve this, it is imperative that the initiative 
secure broad political commitment.  
 
5.9.4 Reorientating the health system 
 
The health system, in many ways, has several constraints to the delivery of chronic 
disease services. In order to achieve improved quality and access to services, all the 
building blocks of the health system including service delivery, workforce, informatics, 
equipment and technologies, finance and leadership need to be strengthened 
(33;102;158). The chronic care model needs to be developed at primary health care level 
incorporating adequate training of health care workers and support staff, provision of the 
necessary equipment and maintaining a supply of appropriate drug therapy.  
 
Besides political will and dedicated non-governmental organisations, the success of NCD 
programme is incumbent on the health care worker (35). The „brain drain‟ deprives 
Africa of invaluable and medical and technical management and support (35). Having 
skilled and motivated medical and support staff in sufficient numbers, particularly in 
areas where access poses a significant problem, is intrinsic to delivering appropriate 
health services and ultimately improving health outcomes (159). The patient-provider 
relationship has been emphasised with patients who are actively engaged by the health 
care worker in terms of treatment, results of measurements and patient education having 
better health outcomes. Self management must form an integral part of quality primary 
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care for chronic diseases and this can only be achieved through comprehensive education 
and involvement.  
 
5.10 LIMITATIONS 
 
The study was affected by the following limitations:  
 
a) Study participation depended on the availability of members of the community 
within the allocated times of the study period. The results, as such, are not 
generalizable to the greater community outside of this group. 
b) Participants refusing to have blood samples drawn have affected the sampling 
strategy as they were excluded from the study on this basis.  
c) All behaviours and practices were self-reported by the study participants. There 
was no means of verifying the data collected. The information reported was also 
subject to recall bias. Some areas covered by the questions were highly sensitive. 
Though the interviewers were trained to deal with this issue, this did not 
guarantee open and honest answers. 
d) Blood samples drawn were not fasting samples. Abnormal results warranted clinic 
referrals for either further investigation or for formal fasting blood samples if 
these were necessitated.   
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e) The blood collected for the lipid profile testing had been incorrectly stored and 
the laboratory was unable to analyse these samples. HbA1c was used as a 
surrogate for fasting plasma glucose samples given resource constraints to the 
project.  Eleven samples drawn for HbA1c testing were unaccounted for by the 
laboratory.  As a result of this, the prevalence of the MS considering the 
cholesterol criteria (9) could not be ascertained. It is likely that the prevalence 
data of the MS presented in this study is under-estimated because of this.  
f) Some variables (e.g. Education levels of the participant, alcohol consumption) 
were dichotomized to simplify the statistical analysis and allow for ease of 
interpretation and presentation of results. However, it is appreciated that in 
dichotomizing variables, much information could be lost, so the statistical power 
to detect a relation between the variable and outcome is reduced. 
g) HIV testing was not conducted and no questions regarding the use of HAART 
were asked. This was not done because of the concern that people would decline 
participation as a result of the stigma associated with HIV testing and this would 
affect the sampling strategy. In doing so, the disease of burden attributable to the 
complex interaction between HIV and CVD could not be estimated.  
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5.11 SUMMARY OF THE CHAPTER 
 
The analysis describes the huge, and probably underestimated, burden of chronic diseases 
in the Johannesburg Health District, South Africa. Low levels of education have 
consistently been shown to be associated with disease.  Females have emerged as a high 
risk priority group with levels of obesity exceeding 50%. Community-based screening 
programmes have been shown to be an effective tool in detecting disease in minority and 
low income populations. The findings of this study support the screening of cardio-
metabolic diseases from as early as 30 years of age in males and 40 years of age in 
females.  
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CHAPTER 6 
CONCLUSIONS AND RECOMMENDATIONS 
 
This chapter summarizes the key findings of the study. Possible recommendations are 
then discussed. 
 
6.1  CONCLUSIONS 
 
The growing prevalence of cardio-metabolic diseases continue to pressurise limited 
health finances, to the point where their collective impact cannot be ignored (8). Health 
care workers and policy makers alike are facing what is tantamount to an epidemic. The 
findings of this study indicate that the extent of the burden of chronic diseases in the 
Johannesburg Health District has been grossly underestimated.  
 
6.1.1 Objective 1 
To describe the study population in terms of socio-demographic factors  
 
The study population is predominantly black with most participants being female (63%). 
The median age was 44 years (IQR 30-56). Most participants are unemployed (50%) and 
most had less than Grade 12 education (59%). Thirty one percent of the study population 
is dependent on social remittances from the government as a source of income.  
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6.1.2 Objective 2 
To explore the prevalence and risk factors associated with the development of the 
following cardio-metabolic diseases:  
a. Diabetes mellitus 
b. Hypertension 
c. Obesity 
 
Female gender is highly associated with being overweight and obese. The development 
of the DM, HPT and obesity is strongly associated with lower levels of education.  
 
a. Diabetes mellitus 
The prevalence of DM is 14% (47/326) with similar distributions amongst males and 
females. Most diabetics are poorly controlled (66%). Almost 20% of participants 
interviewed are classified as pre-diabetic.  
 
b. Hypertension 
The prevalence of HPT is 58% (197/337) with similar distribution in females (60%) and 
males (56%). There is a high number (112/220, 51%) of „prehypertensive‟ participants. 
Most diagnosed with HPT are poorly controlled (61%) with only 5% recording BP within 
the normal range.  
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c. Obesity 
Thirty percent of participants (101/337) are classified as overweight in this study. The 
levels of obesity is marked (133/337, 39%) with predominance among females (114/213, 
54%).  
 
6.1.3 Objective 3 
To examine the associations among these major risk factors  
 
The diseases discussed are risk factors for the development of other cardio-metabolic 
diseases (e.g. a previous history of HPT has been associated with DM). This 
demonstrates that these diseases are very much linked and draws attention to the clinical 
value in screening for all cardio-metabolic diseases. An increase in the BMI is associated 
with an increase in both SBP and DBP but the rate of increase is not consistent. Removal 
of outlier values yielded the same relationship implying the generalizability of the study 
findings. BMI values are also associated with an increase in HbA1c levels – an association 
that improved from 1.45% to 12% with removal of the outlying values of HbA1c. The 
outliers represented older, married individuals of both genders with lower educational 
levels and a clinical history of DM and HPT.  
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6.1.4 Objective 4 
To determine the community prevalence of the MS and the major risk factors that 
predisposes individuals in this community to the development of the MS (as defined 
in Chapter 3: 3.6.1.2 Clinical variables (Metabolic syndrome) 
 
The prevalence of the MS in the study population is 31%. One hundred and ninety five 
females (92%) and 64 males (52%) met the IDF criteria for WC. On multivariate 
analysis, female gender and a previous history of DM are strongly associated with the 
development of the MS. Increasing SBP and WC was also implicated in the development 
of the MS.  
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6.2 RECOMMENDATIONS 
 
6.2.1 Engage the community in health promotion strategies  
 
Raising public awareness among the community influences early diagnosis, brings risk 
factors to the fore and allows the families and communities of the patients to participate 
more actively in the patients‟ management. These strategies need to extend beyond the 
clinic environment.  
 
Health messages that are developed should be culturally appropriate and reach the 
community through a wide array of media including television, radio and print. 
Encouraging behaviour change can prove quite challenging. Community programmes can 
be used to provide messaging on safe and effective methods for prevention and 
management of diseases including walking, jogging and ball games. Having said this, 
environments would need to be created to allow for these activities to occur safely. 
Nutrition and physical activity needs to be integrated into the core curriculum at schools 
and food snack sold or provided should be nutritious. Community or school food gardens 
are an ideal way to ensure healthy foods while engaging large sectors of the community.  
 
Understandably, the presence of the Changing Diabetes
®
 Bus in the community piqued 
the interest of the residents. All residents who wished to be tested received a simple 
screening on the bus. Apart from receiving health education, the residents had their BP, 
random glucose and BMI measured. The findings were explained to them and were 
accompanied by a clinical referral in the case of abnormal findings. This implies, to some 
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degree, the level of interest that the community has in knowing and understanding their 
health status and alludes to the success that future screening programmes of this nature 
may enjoy.  
 
6.2.2 Identify females as a high priority group 
 
Females need to be targeted primarily for future interventions. The data suggests that 
females have a disproportionately higher risk of developing associated CVD risk factors. 
Further, the high levels of obesity among women is confirmed by this study and 
substantiated by preceding studies. Females are known to have better health seeking 
behaviour patterns than males. Thus, every opportunity that a female presents herself to 
the health services should represent an opportunity to screen and educate her about these 
diseases but more importantly, to reinforce positive lifestyle choices. 
 
6.2.3 Strengthening the health system  
 
The population of Chiawelo appears to be in an epidemiological transition. As such, 
greater emphasis needs to be placed on screening programmes and follow up, as well as 
endorsing lifestyle modification to avert the development of these chronic metabolic 
conditions. Integration of health services are needed at clinic level so that the individual 
cardio-metabolic diseases are not addressed in isolation. This can be facilitated through 
education and training of health care workers and clinic personnel to optimally diagnose 
and manage these conditions as a single entity. Cost-effective interventions tackling 
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obesity through improved diets and increased physical activity need to form part of a 
package addressing chronic diseases (38).  
 
Low levels of education have consistently been linked to all chronic diseases within the 
scope of this report. To the patient, understanding the disease process gives more 
meaning to the management and promotes a greater desire to be involved in treatment 
strategies. The literature shows that health care workers engaging patients result in better 
health outcomes. 
 
6.2.4 Clinical implications on screening practices 
 
BP measurements reaching levels of prehypertension or above (SBP ≥ 130 mmHg and/or 
DBP ≥ 85 mmHg) requires treatment including weight loss and exercise followed by 
drug therapy after an appropriate trial of lifestyle modification (97). This statement has 
massive ramifications for this population as this study found prehypertension levels of 
51%.  Given the median ages described in Table 4.10, selective screening for HPT in this 
population should occur as early as 40 years in females [Figure 6.1(a)] and 30 years in 
males [Figure 6.1(b)]. Hypertension was identified among both males and females as 
young as 20-29 years of age. It will not prove cost effective to reduce the screening age to 
this level, but perhaps factors identified on multivariate analysis in this population 
(weight) could be considered together with clinical presentation and the presence of other 
recognised risk factors (97) when deciding whether to screen for HPT or not.  
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When considering DM, there does not appear to be a prescribed age at which screening is 
recommended. The findings of this study point to selective screening for DM as early as 
50 years of age in females [Figure 6.2(a)] and 55 years of age in males [Figure 6.2(b)]. 
As with HPT, both genders presented as early as 20-29 years of age with IGT and DM. 
Screening for a previous diagnosis of HPT would be an additional consideration for 
screening at this age group, over and above the presence of clinical judgment and 
recognised risk factors.  
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a. Females 
 
b. Males 
 
Figure 6.1: Prevalence of HPT identifying target ages for screening 
†
South African Hypertension Guideline 2006  
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People with chronic diseases of lifestyle such as HPT, DM and CVD have long been 
identified as high risk target groups for primary and secondary prevention of obesity (64). 
This study identified 47 years of age in females and 49 years in males as selective 
screening ages for being overweight. This is a guide only and patients should be screened 
based on clinician presentation. Obesity was further identified as a particular concern in 
the study population with 54% of females being classified as obese.  
 
Community-based screening programmes have been shown to be an effective tool in 
detecting disease in minority and low income populations (160). The findings of this 
study support the screening of cardio-metabolic diseases from as early as 30 years of age 
in males and 40 years of age in females.  
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a. Female 
 
b. Male 
 
*National Programme for the control and management of diabetes type 2 at primary level (96) 
 
 
Figure 6.2: Prevalence of DM identifying target ages for screening 
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6.2.5 Improving screening and surveillance strategies 
 
Clinical decisions and policy implementation is guided by the „local‟ data on disease 
prevalence. It is thus imperative that this information be as accurate as possible. 
Community-based screening programmes have been shown to be an effective tool in 
detecting disease in minority and low income populations. While remaining cognisant of 
the current HPT and DM guidelines in use in South Africa, it is the findings of this study 
to support the screening of the cardio-metabolic diseases from as early as 30 years of age 
in males and 40 years of age in females. 
 
Prior to initiating a system of surveillance, buy-in by those tasked with collecting the 
information would be advisable, as this would assist with sustainability of the 
intervention. The tools used for this purpose should be easy to understand, simple to 
complete and allow for comparison between clinics and provinces alike. The use of the 
WHO STEPwise tool is a useful starting block and should be modified in according to 
the local requirements of a surveillance programme.  The tool can be implemented at a 
single clinic and be extended to other clinics, all the while identifying strengths and 
weaknesses of implementation and acting on these accordingly.  
 
Data collected over time allows for analysis of trends and helps assess the effectiveness 
of interventions. The clinic staff that collects the data must be privy to the findings and 
witness the translation to clinic practice through policy evaluation and changes. In doing 
so, they will remain motivated to collect the data, as they will be able to track the 
positive, or negative, influence of their service provision.  
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Apart from improvements in clinical management, the surveillance data should identify 
gaps in the quality of service at PHC facilities. The additional value of this data is that it 
would guide health care worker training and subsequently, service provision. The training 
should be conducted regularly.  
 
6.2.6 Further research 
 
The following research areas are vital as the findings would provide insight into the 
screening, management and surveillance of NCDs particularly pertaining to South Africa: 
 
a. Evaluation of the clinical and cost effective utilisation of resources dedicated to 
the care of patients with NCDs and the use of these to direct preventative 
measures 
b. Identification and the assessment of the most cost-effective and culturally 
appropriate strategies tackling unhealthy diets, physical inactivity and obesity in 
South Africa. 
c. Investigation into the impact and effectiveness of food labelling  
d. Evaluation of strategies to integrate the management of NCDs and 
communicable diseases 
e. Understanding the development and provision of culturally appropriate 
resources with which to train health care-workers 
f. Determining the levels of physical activity among Gauteng residents using a 
standardized tool 
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g. Understanding the effects of malaria, iron-deficiency anaemia, HIV and 
HAART on HbA1c levels among the various ethnic groups of South Africa 
h. Assessment of the Metabolic Syndrome in the Johannesburg Health District  
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6.3  SUMMARY AND CONCLUSIONS  
 
The global prevalence of NCD is increasing with much of the burden attributable to 
urbanisation and poor lifestyle choices. South Africa suffers a similar fate. In South 
Africa, optimal management extends beyond the disease with individual and health 
system factors impacting considerably of delivery and use of services. This study was a 
community based cross sectional survey conducted in Chiawelo, Soweto in the 
Johannesburg Health District. The findings of this study indicate that the extent of the 
burden of chronic cardio-metabolic diseases in the Johannesburg Health District has been 
grossly underestimated. The prevalence of HPT and DM are high, with poor control and 
obesity levels are reaching epidemic proportions, particularly among females. Low levels 
of education seem to a recurring factor in disease development. Countering the burden of 
chronic disease involves the identification and targeting of females as a high risk priority 
group, engaging the patients and community alike in health promotion programmes and 
developing an adequate, accurate and reproducible system of NCD surveillance. The 
entire process hinges on the strengthening of the health system through retraining of staff, 
sensible following of clinical guidelines and health care workers engaging patients in 
their clinical management. Clinically, it is the findings of this study to support the 
screening of cardio-metabolic diseases from as early as 30 years of age in males and 40 
years of age in females. 
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APPENDIX A: SAMPLING STRATEGIES 
 
1. Study enrolment detail  
 
THE METABOLIC SYNDROME AND ASSOCIATED RISK FACTORS IN THE 
JOHANNESBURG HEALTH DISTRICT 
 
 
STUDY ENROLMENT DETAIL 
   
 
CLUSTER NO: ___ ___ PARTICIPANT NO: ___ ___         STUDY NO: ___ ___ ___ 
 
 
Research assistant: 
Use the map of Chiawelo. Start at the point marked X for each chosen cluster. You have to go to 
every 3rd yard until you have 70 adult participants from each of the 5 clusters. 
 
Select the first yard next to the X on the left side of the street. 
 
Select all the adults who are older than 18 years of age who permanently live in this yard and 
write their names on the sheet named “How to choose the respondent”. Follow the instructions on 
the sheet in order to select a person for the interview. 
 
Write down the cluster and the yard number on the enrolment sheet. 
 
If there are no eligible adults who permanently live in this yard, or if there are people who refuse 
to participate, move clockwise in the street and skip 2 yards. Try the next yard. 
 
Explain the study details and request selected participant‟s signed consent. 
 
 
 
 
 
Address visited: ____________________________________________ 
Name of research assistant: _____________________________________ 
Date of enrolment: _____/_____/ 2009 
Comments by research assistant:   
______________________________________________________________________ 
 
______________________________________________________________________ 
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2. Choosing the respondent 
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APPENDIX B: MEASUREMENT TOOLS 
 
1. Patient information sheet 
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2. Patient consent form 
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3. Patient questionnaire 
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APPENDIX C: PERMISSIONS 
 
1. Ethical clearance 
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2. Post-graduate approval letter 
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APPENDIX D: PATIENT DOCUMENTS 
 
1. Clinic referral letter 
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2. Example of disease information pamphlet 
 
 
 
 
 
